Estrogen	O
decreases	O
TNF	B-protein
gene	O
expression	O
by	O
blocking	O
JNK	B-protein
activity	O
and	O
the	O
resulting	O
production	O
of	O
c-Jun	B-protein
and	O
JunD	B-protein
.	O

Central	O
to	O
the	O
bone-sparing	O
effect	O
of	O
estrogen	O
(	O
E	O
(	O
2	O
)	O
)	O
is	O
its	O
ability	O
to	O
block	O
the	O
monocytic	O
production	O
of	O
the	O
osteoclastogenic	B-protein
cytokine	I-protein
TNF-alpha	I-protein
(	O
TNF	B-protein
)	O
.	O

However	O
,	O
the	O
mechanism	O
by	O
which	O
E	O
(	O
2	O
)	O
downregulates	O
TNF	B-protein
production	O
is	O
presently	O
unknown	O
.	O

Transient	O
transfection	O
studies	O
in	O
HeLa	B-cell_line
cells	I-cell_line
,	O
an	O
E	O
(	O
2	O
)	O
receptor-negative	O
line	O
,	O
suggest	O
that	O
E	O
(	O
2	O
)	O
inhibits	O
TNF	B-protein
gene	O
expression	O
through	O
an	O
effect	O
mediated	O
by	O
estrogen	B-protein
receptor	I-protein
beta	I-protein
(	O
ERbeta	B-protein
)	O
.	O

We	O
also	O
report	O
that	O
in	O
RAW	B-cell_line
264.7	I-cell_line
cells	I-cell_line
,	O
an	O
E	O
(	O
2	O
)	O
receptor-positive	O
murine	O
monocytic	O
line	O
,	O
E	O
(	O
2	O
)	O
downregulates	O
cytokine-induced	O
TNF	B-protein
gene	O
expression	O
by	O
decreasing	O
the	O
activity	O
of	O
the	O
Jun	B-protein
NH	I-protein
(	I-protein
2	I-protein
)	I-protein
-terminal	I-protein
kinase	I-protein
(	O
JNK	B-protein
)	O
.	O

The	O
resulting	O
diminished	O
phosphorylation	O
of	O
c-Jun	B-protein
and	O
JunD	B-protein
at	O
their	O
NH	B-protein
(	I-protein
2	I-protein
)	I-protein
-termini	I-protein
decreases	O
the	O
ability	O
of	O
these	O
nuclear	O
proteins	O
to	O
autostimulate	O
the	O
expression	O
of	O
the	O
c-Jun	B-DNA
and	I-DNA
JunD	I-DNA
genes	I-DNA
,	O
thus	O
leading	O
to	O
lower	O
production	O
of	O
c-Jun	B-protein
and	O
JunD	B-protein
.	O

The	O
consequent	O
decrease	O
in	O
the	O
nuclear	O
levels	O
of	O
c-Jun	B-protein
and	O
JunD	B-protein
leads	O
to	O
diminished	O
binding	O
of	O
c-Jun/c-Fos	B-protein
and	O
JunD/c-Fos	B-protein
heterodimers	I-protein
to	O
the	O
AP-1	B-DNA
consensus	I-DNA
sequence	I-DNA
in	O
the	O
TNF	B-DNA
promoter	I-DNA
and	O
,	O
thus	O
,	O
to	O
decreased	O
transactivation	O
of	O
the	O
TNF	B-DNA
gene	I-DNA
.	O

Estrogen	NULL
decreases	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
blocking	NULL
JNK	NULL
activity	NULL
and	NULL
the	NULL
resulting	NULL
production	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
Sunil	NULL
Srivastava	NULL
,	NULL
M.	NULL
Neale	NULL
Weitzmann	NULL
,	NULL
'	NULL
Simone	NULL
Cenci	NULL
,	NULL
!	NULL
'	NULL

F.	NULL
Patrick	NULL
Ross	NULL
,	NULL
``	NULL
Stuart	NULL
Adler	NULL
,	NULL
``	NULL
and	NULL
Roberto	NULL
Pacifici	NULL
'	NULL
Division	NULL
of	NULL
Bone	NULL
and	NULL
Mineral	NULL
Diseases	NULL
,	NULL
*Department	NULL
of	NULL
Pathology	NULL
,	NULL
and	NULL
*Department	NULL
of	NULL
Obstetric	NULL
and	NULL
Gynecology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
and	NULL
Barnes-Jewish	NULL
Hospital	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
,	NULL
USA	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
:	NULL
Roberto	NULL
Pacifici	NULL
,	NULL
Division	NULL
of	NULL
Bone	NULL
and	NULL
Mineral	NULL
Diseases	NULL
,	NULL
Barnes-Jewish	NULL
Hospital	NULL
,	NULL
North	NULL
,	NULL
216	NULL
S.	NULL
Kings	NULL
highway	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
,	NULL
USA	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
314	NULL
)	NULL
454-8407	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
314	NULL
)	NULL
454-5047	NULL
;	NULL
E-Mail	NULL
:	NULL
Pacifici	NULL
@	NULL
imgate.wustL.edu	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
April	NULL
15	NULL
,	NULL
1999	NULL
,	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
June	NULL
30	NULL
,	NULL
1999	NULL
.	NULL

Central	NULL
to	NULL
the	NULL
bone-sparing	NULL
effect	NULL
of	NULL
estrogen	NULL
(	NULL
E	NULL
;	NULL
)	NULL
is	NULL
its	NULL
ability	NULL
to	NULL
block	NULL
the	NULL
monocytic	NULL
production	NULL
of	NULL
the	NULL
osteoclastogenic	NULL
cytokine	NULL
TNF-Q	NULL
(	NULL
TNF	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
E	NULL
,	NULL
downregulates	NULL
TNF	NULL
production	NULL
is	NULL
presently	NULL
unknown	NULL
.	NULL

Transient	NULL
transfection	NULL
studies	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
an	NULL
E	NULL
,	NULL
receptor-negative	NULL
line	NULL
,	NULL
suggest	NULL
that	NULL
E	NULL
;	NULL
inhibits	NULL
TNF	NULL
gene	NULL
expression	NULL
through	NULL
an	NULL
effect	NULL
mediated	NULL
by	NULL
estrogen	NULL
receptor	NULL
B	NULL
(	NULL
ERf	NULL
)	NULL
.	NULL

We	NULL
also	NULL
report	NULL
that	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
an	NULL
E	NULL
;	NULL
receptor-positive	NULL
murine	NULL
monocytic	NULL
line	NULL
,	NULL
E	NULL
;	NULL
downregulates	NULL
cytokine-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
decreasing	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Jun	NULL
NH	NULL
;	NULL
-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
diminished	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
at	NULL
their	NULL
decreases	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
nuclear	NULL
proteins	NULL
to	NULL
autostimulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
genes	NULL
,	NULL
thus	NULL
leading	NULL
to	NULL
lower	NULL
production	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
.	NULL

The	NULL
consequent	NULL
decrease	NULL
in	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
leads	NULL
to	NULL
diminished	NULL
binding	NULL
of	NULL
c-Jun/c-Fos	NULL
and	NULL
JunD/c-Fos	NULL
heterodimers	NULL
to	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
to	NULL
decreased	NULL
transactivation	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

104:503-513	NULL
(	NULL
1999	NULL
)	NULL
.	NULL

Introduction	NULL
It	NULL
is	NULL
now	NULL
recognized	NULL
that	NULL
one	NULL
of	NULL
the	NULL
main	NULL
mechanisms	NULL
by	NULL
which	NULL
estrogen	NULL
(	NULL
E	NULL
;	NULL
)	NULL
deficiency	NULL
causes	NULL
bone	NULL
loss	NULL
is	NULL
by	NULL
stimulating	NULL
osteoclast	NULL
formation	NULL
(	NULL
1	NULL
)	NULL
,	NULL
a	NULL
process	NULL
enhanced	NULL
by	NULL
several	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

Among	NULL
them	NULL
is	NULL
TNF-	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
a	NULL
protein	NULL
produced	NULL
mainly	NULL
by	NULL
cells	NULL
of	NULL
the	NULL
monocyte/macrophage	NULL
lineage	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Once	NULL
released	NULL
in	NULL
the	NULL
bone	NULL
microenvironment	NULL
,	NULL
TNF	NULL
stimulates	NULL
osteoclast	NULL
formation	NULL
,	NULL
in	NULL
part	NULL
by	NULL
inducing	NULL
the	NULL
production	NULL
of	NULL
M-CSF	NULL
by	NULL
bone	NULL
marrow	NULL
stromal	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

M-CSF	NULL
,	NULL
along	NULL
with	NULL
osteoprotegerin	NULL
ligand	NULL
(	NULL
OPGL	NULL
;	NULL
also	NULL
known	NULL
as	NULL
ODF/TRANCE/RANKL	NULL
)	NULL
(	NULL
7	NULL
)	NULL
,	NULL
is	NULL
an	NULL
essential	NULL
stimulator	NULL
of	NULL
osteoclast	NULL
precursor	NULL
proliferation	NULL
and	NULL
differentiation	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

Studies	NULL
in	NULL
ovariectomized	NULL
mice	NULL
,	NULL
an	NULL
established	NULL
experimental	NULL
model	NULL
of	NULL
postmenopausal	NULL
osteoporosis	NULL
(	NULL
1	NULL
)	NULL
,	NULL
have	NULL
provided	NULL
compelling	NULL
evidence	NULL
that	NULL
increased	NULL
production	NULL
of	NULL
TNF	NULL
plays	NULL
a	NULL
critical	NULL
causal	NULL
role	NULL
in	NULL
ovariectomy-induced	NULL
bone	NULL
loss	NULL
.	NULL

This	NULL
evidence	NULL
includes	NULL
the	NULL
finding	NULL
that	NULL
treatment	NULL
with	NULL
the	NULL
TNF	NULL
inhibitor	NULL
TNF-binding	NULL
protein	NULL
completely	NULL
prevents	NULL
ovariectomy-induced	NULL
bone	NULL
loss	NULL
(	NULL
11	NULL
)	NULL
and	NULL
the	NULL
report	NULL
that	NULL
transgenic	NULL
mice	NULL
insensitive	NULL
to	NULL
TNF	NULL
owing	NULL
to	NULL
the	NULL
overexpression	NULL
of	NULL
a	NULL
soluble	NULL
TNF	NULL
receptor	NULL
are	NULL
also	NULL
protected	NULL
against	NULL
ovariectomy-induced	NULL
bone	NULL
loss	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Evidence	NULL
has	NULL
also	NULL
accumulated	NULL
that	NULL
demonstrates	NULL
that	NULL
E	NULL
,	NULL
downregulates	NULL
the	NULL
production	NULL
and/or	NULL
the	NULL
release	NULL
of	NULL
TNF	NULL
by	NULL
several	NULL
cell	NULL
lineages	NULL
,	NULL
including	NULL
bone	NULL
marrow	NULL
monocytes	NULL
and	NULL
bone	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
monocytes	NULL
and	NULL
osteoblasts	NULL
,	NULL
TNF	NULL
protein	NULL
and	NULL
TNF	NULL
mRNA	NULL
levels	NULL
are	NULL
increased	NULL
after	NULL
natural	NULL
or	NULL
surgical	NULL
menopause	NULL
and	NULL
decrease	NULL
with	NULL
E	NULL
;	NULL
replacement	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

E	NULL
;	NULL
inhibits	NULL
TNF	NULL
production	NULL
by	NULL
direct	NULL
effects	NULL
on	NULL
target	NULL
cells	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
in	NULL
vitro	NULL
E	NULL
;	NULL
treatment	NULL
decreases	NULL
TNF	NULL
levels	NULL
in	NULL
cultures	NULL
of	NULL
murine	NULL
bone	NULL
marrow	NULL
monocytes	NULL
(	NULL
16	NULL
)	NULL
and	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
17	NULL
)	NULL
and	NULL
decreases	NULL
TNF	NULL
mRNA	NULL
expression	NULL
in	NULL
a	NULL
murine	NULL
monocytic	NULL
cell	NULL
line	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
studies	NULL
demonstrate	NULL
that	NULL
the	NULL
bone-sparing	NULL
effect	NULL
of	NULL
Ez	NULL
is	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
a	NULL
result	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
downregulate	NULL
the	NULL
bone	NULL
marrow	NULL
levels	NULL
of	NULL
TNF	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
TNF	NULL
as	NULL
key	NULL
enhancer	NULL
of	NULL
bone	NULL
resorption	NULL
in	NULL
E-deficient	NULL
rodents	NULL
and	NULL
humans	NULL
has	NULL
been	NULL
defined	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
E	NULL
,	NULL
downregulates	NULL
TNF	NULL
production	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

The	NULL
TNF	NULL
gene	NULL
is	NULL
transcriptionally	NULL
silent	NULL
in	NULL
unstimulated	NULL
monocytes	NULL
and	NULL
is	NULL
rapidly	NULL
transcribed	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
signals	NULL
,	NULL
such	NULL
as	NULL
endotoxin	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
and	NULL
cytokines	NULL
including	NULL
IL-1	NULL
and	NULL
TNF	NULL
itself	NULL
(	NULL
19-22	NULL
)	NULL
.	NULL

Although	NULL
LPS	NULL
is	NULL
the	NULL
major	NULL
inducer	NULL
of	NULL
TNF	NULL
in	NULL
infectious	NULL
disease	NULL
,	NULL
in	NULL
physiological	NULL
conditions	NULL
the	NULL
production	NULL
of	NULL
TNF	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
is	NULL
mostly	NULL
induced	NULL
by	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

Low	NULL
concentrations	NULL
of	NULL
IL-1	NULL
and	NULL
TNF	NULL
are	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
constitutively	NULL
produced	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Monocyte	NULL
stimulation	NULL
with	NULL
either	NULL
IL-1	NULL
or	NULL
TNF	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
AP-1	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
AP-1	NULL
family	NULL
comprises	NULL
a	NULL
group	NULL
of	NULL
inducible	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
a	NULL
common	NULL
cis-acting	NULL
element	NULL
known	NULL
as	NULL
the	NULL
TPA	NULL
response	NULL
element	NULL
(	NULL
TRE	NULL
)	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
include	NULL
members	NULL
of	NULL
the	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|_	NULL
Number	NULL
4	NULL
503	NULL
504	NULL
Jun	NULL
,	NULL
Fos	NULL
,	NULL
and	NULL
ATF	NULL
(	NULL
CREB	NULL
)	NULL
families	NULL
of	NULL
nuclear	NULL
proteins	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
Jun	NULL
family	NULL
consists	NULL
of	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Fos	NULL
family	NULL
includes	NULL
c-Fos	NULL
,	NULL
Fra-1	NULL
,	NULL
Fra-2	NULL
,	NULL
FosB	NULL
,	NULL
and	NULL
FosB2	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
TRE	NULL
sites	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
,	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
AP-1	NULL
is	NULL
known	NULL
to	NULL
be	NULL
a	NULL
critical	NULL
inducer	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
TNF	NULL
gene	NULL
expression	NULL
(	NULL
27	NULL
)	NULL
,	NULL
suggests	NULL
that	NULL
E	NULL
;	NULL
could	NULL
downregulate	NULL
the	NULL
production	NULL
of	NULL
TNF	NULL
by	NULL
decreasing	NULL
the	NULL
ability	NULL
of	NULL
AP-1	NULL
to	NULL
transactivate	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
,	NULL
on	NULL
cytokine-induced	NULL
monocytic	NULL
production	NULL
of	NULL
TNF	NULL
.	NULL

We	NULL
report	NULL
that	NULL
E	NULL
,	NULL
downregulates	NULL
cytokine-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
decreasing	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Jun	NULL
NH	NULL
>	NULL
-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
through	NULL
an	NULL
effect	NULL
that	NULL
is	NULL
likely	NULL
mediated	NULL
by	NULL
ERB	NULL
.	NULL

Decreased	NULL
JNK	NULL
activity	NULL
results	NULL
in	NULL
blunted	NULL
production	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
,	NULL
thus	NULL
leading	NULL
to	NULL
decreased	NULL
binding	NULL
of	NULL
c-Jun/Fos	NULL
and	NULL
JunD/Fos	NULL
heterodimers	NULL
to	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

Methods	NULL
Unless	NULL
otherwise	NULL
specified	NULL
,	NULL
all	NULL
reagents	NULL
and	NULL
media	NULL
were	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

RAW	NULL
264.7	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
Maryland	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
were	NULL
maintained	NULL
in	NULL
phenol	NULL
red-free	NULL
media	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
New	NULL
York	NULL
,	NULL
USA	NULL
)	NULL
and	NULL
10	NULL
%	NULL
charcoal-stripped	NULL
serum	NULL
.	NULL

RAW	NULL
264.7	NULL
and	NULL
HeLa	NULL
cell	NULL
transfection	NULL
and	NULL
CAT	NULL
assay	NULL
.	NULL

RAW	NULL
264.7	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2.5	NULL
x	NULL
10°	NULL
and	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
,	NULL
respectively	NULL
.	NULL

Cells	NULL
were	NULL
pretreated	NULL
with	NULL
E	NULL
;	NULL
,	NULL
(	NULL
10°	NULL
M	NULL
)	NULL
or	NULL
control	NULL
vehicle	NULL
(	NULL
ethanol	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
then	NULL
transfected	NULL
with	NULL
4	NULL
ug	NULL
of	NULL
the	NULL
appropriate	NULL
vectors	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
-galactosidase	NULL
.	NULL

All	NULL
transfec-tions	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
12	NULL
L	NULL
of	NULL
Lipofectamine	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
for	NULL
5	NULL
hours	NULL
without	NULL
serum	NULL
.	NULL

Once	NULL
trans-fected	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
and	NULL
either	NULL
E	NULL
;	NULL
or	NULL
control	NULL
vehicle	NULL
for	NULL
12	NULL
hours	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
effect	NULL
of	NULL
E2	NULL
on	NULL
TNF	NULL
transcription	NULL
,	NULL
either	NULL
a	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5°	NULL
promoter	NULL
region	NULL
plus	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3°	NULL
UTR	NULL
,	NULL
or	NULL
a	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
but	NULL
lacking	NULL
the	NULL
3	NULL
``	NULL
UTR	NULL
region	NULL
,	NULL
was	NULL
used	NULL
.	NULL

Both	NULL
constructs	NULL
were	NULL
developed	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
and	NULL
provided	NULL
by	NULL
B.	NULL
Beutler	NULL
(	NULL
Southwestern	NULL
Univer-sity	NULL
,	NULL
Dallas	NULL
,	NULL
Texas	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
plus	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3	NULL
``	NULL
UTR	NULL
carrying	NULL
a	NULL
mutation	NULL
previously	NULL
shown	NULL
to	NULL
silence	NULL
the	NULL
TRE	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
(	NULL
27	NULL
)	NULL
.	NULL

This	NULL
mutation	NULL
was	NULL
generated	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
30	NULL
)	NULL
and	NULL
consisted	NULL
of	NULL
the	NULL
substitution	NULL
of	NULL
the	NULL
TG	NULL
nucleotides	NULL
at	NULL
positions	NULL
-700	NULL
to	NULL
-699	NULL
with	NULL
GT	NULL
nucleotides	NULL
.	NULL

Briefly	NULL
,	NULL
nonoverlapping	NULL
mutagenesis	NULL
primers	NULL
binding	NULL
to	NULL
different	NULL
template	NULL
strands	NULL
were	NULL
synthesized	NULL
with	NULL
a	NULL
primer	NULL
carrying	NULL
the	NULL
TG-	NULL
>	NULL
GT	NULL
substitutions	NULL
.	NULL

Introduction	NULL
of	NULL
the	NULL
substituted	NULL
bases	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
(	NULL
5	NULL
ng/mL	NULL
each	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
RAW	NULL
264.7	NULL
cells	NULL
express	NULL
functional	NULL
ERs	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
estrogen-responsive	NULL
element-driven	NULL
(	NULL
ERE-driven	NULL
)	NULL
and	NULL
CAT	NULL
reporter	NULL
construct	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
either	NULL
E	NULL
;	NULL
(	NULL
10-°M	NULL
)	NULL
or	NULL
control	NULL
vehicle	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
repressive	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
on	NULL
TNF	NULL
gene	NULL
expression	NULL
are	NULL
mediated	NULL
by	NULL
estrogen	NULL
receptor	NULL
&	NULL
(	NULL
ER	NULL
)	NULL
or	NULL
ERB	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
2.5	NULL
ug	NULL
of	NULL
TNFE/CAT	NULL
reporter	NULL
plasmid	NULL
,	NULL
1	NULL
jug	NULL
of	NULL
B-galactosidase	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
0.5	NULL
pug	NULL
of	NULL
either	NULL
ERQ	NULL
expression	NULL
vector	NULL
(	NULL
32	NULL
)	NULL
or	NULL
ERB	NULL
expression	NULL
vector	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
T.	NULL
Brown	NULL
,	NULL
Pfizer	NULL
,	NULL
Groton	NULL
,	NULL
Connecticut	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
expression	NULL
of	NULL
functional	NULL
ERs	NULL
in	NULL
transfected	NULL
HeLa	NULL
cells	NULL
,	NULL
parallel	NULL
experiments	NULL
were	NULL
conducted	NULL
by	NULL
cotransfecting	NULL
HeLa	NULL
cells	NULL
with	NULL
either	NULL
ERG	NULL
or	NULL
ERB	NULL
expression	NULL
vector	NULL
and	NULL
the	NULL
Vit2-P36L	NULL
ERE/luciferase	NULL
reporter	NULL
plasmid	NULL
(	NULL
33	NULL
)	NULL
and	NULL
then	NULL
treating	NULL
with	NULL
either	NULL
E	NULL
;	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
or	NULL
control	NULL
vehicle	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
treatment	NULL
period	NULL
and	NULL
lysed	NULL
by	NULL
3	NULL
freeze-thaw	NULL
cycles	NULL
in	NULL
200	NULL
uL	NULL
of	NULL
250	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
34	NULL
)	NULL
.	NULL

CAT	NULL
,	NULL
-galactosidase	NULL
,	NULL
and	NULL
luciferase	NULL
activities	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
by	NULL
Godambe	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
)	NULL
,	NULL
Hall	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
normalized	NULL
CAT	NULL
or	NULL
luciferase	NULL
activity	NULL
after	NULL
correction	NULL
for	NULL
transfection	NULL
efficiency	NULL
using	NULL
the	NULL
cotransfected	NULL
B-galactosidase	NULL
control	NULL
for	NULL
each	NULL
well	NULL
.	NULL

TNF	NULL
ELISA	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
levels	NULL
of	NULL
TNF	NULL
secreted	NULL
by	NULL
RAW	NULL
264.7	NULL
cells	NULL
into	NULL
the	NULL
culture	NULL
medium	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
24	NULL
hours	NULL
with	NULL
5	NULL
ng/mL	NULL
each	NULL
of	NULL
murine	NULL
IL-1	NULL
and	NULL
human	NULL
TNF	NULL
.	NULL

Levels	NULL
of	NULL
TNF	NULL
were	NULL
then	NULL
determined	NULL
using	NULL
an	NULL
ELISA	NULL
specific	NULL
for	NULL
murine	NULL
TNF	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
this	NULL
assay	NULL
was	NULL
25	NULL
pg/mL	NULL
.	NULL

RT-PCR	NULL
for	NULL
ER	NULL
&	NULL
and	NULL
ERB	NULL
mRNA	NULL
.	NULL

RT-PCR	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Lu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
38	NULL
)	NULL
with	NULL
minor	NULL
mod-ifications	NULL
.	NULL

A	NULL
total	NULL
of	NULL
2.5	NULL
ig	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
first-strand	NULL
reactions	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
uL	NULL
using	NULL
30	NULL
cycles	NULL
of	NULL
1	NULL
minute	NULL
at	NULL
94°C	NULL
,	NULL
1	NULL
minute	NULL
at	NULL
54°C	NULL
,	NULL
and	NULL
2	NULL
minutes	NULL
at	NULL
72°C	NULL
.	NULL

Forward	NULL
and	NULL
reverse	NULL
primers	NULL
for	NULL
ERQ	NULL
were	NULL
CCT	NULL
GGA	NULL
GAA	NULL
CGA	NULL
GCC	NULL
CA-3	NULL
'	NULL
and	NULL
5-AAG	NULL
GCA	NULL
CTG	NULL
ACC	NULL
ATC	NULL
TGG	NULL
TC-5	NULL
``	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
for	NULL
ERB	NULL
,	NULL
AAC	NULL
AAA	NULL
GCC	NULL
AAG	NULL
AGA-3	NULL
'	NULL
and	NULL
GCT	NULL
CTT	NULL
ACT	NULL
GTC	NULL
CTC	NULL
TGT	NULL
CG-3	NULL
'	NULL
,	NULL
respectively	NULL
.	NULL

PCR	NULL
products	NULL
(	NULL
10	NULL
LL	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
,	NULL
and	NULL
bands	NULL
were	NULL
viewed	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

RNA	NULL
purification	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
RAW	NULL
264.7	NULL
cells	NULL
was	NULL
extracted	NULL
using	NULL
Trizol	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
and	NULL
was	NULL
quantified	NULL
by	NULL
spectrophotometry	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
RNA	NULL
(	NULL
10	NULL
pug	NULL
per	NULL
lane	NULL
)	NULL
were	NULL
elec-trophoresed	NULL
on	NULL
1	NULL
%	NULL
Seakem	NULL
agarose/formaldehyde	NULL
(	NULL
0.23	NULL
%	NULL
)	NULL
gels	NULL
(	NULL
39	NULL
)	NULL
and	NULL
transferred	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
hybridized	NULL
in	NULL
Hybri-zol	NULL
(	NULL
Oncor	NULL
Inc.	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Maryland	NULL
,	NULL
USA	NULL
)	NULL
with	NULL
*2P-labeled	NULL
probes	NULL
for	NULL
16	NULL
hours	NULL
at	NULL
42°C	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
3	NULL
times	NULL
in	NULL
2x	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
tem-perature	NULL
,	NULL
and	NULL
once	NULL
in	NULL
0.2	NULL
%	NULL
SSC/0.02	NULL
%	NULL
SDS	NULL
at	NULL
56°C	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

For	NULL
autoradiography	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-OMAT	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
,	NULL
Rochester	NULL
,	NULL
New	NULL
York	NULL
,	NULL
USA	NULL
)	NULL
at	NULL
-80°C	NULL
for	NULL
the	NULL
appropriate	NULL
duration	NULL
.	NULL

As	NULL
a	NULL
TNF	NULL
probe	NULL
,	NULL
we	NULL
used	NULL
a	NULL
full-length	NULL
cDNA	NULL
specific	NULL
for	NULL
murine	NULL
TNF	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
,	NULL
labeled	NULL
with	NULL
[	NULL
P	NULL
]	NULL
dCTP	NULL
using	NULL
the	NULL
random	NULL
priming	NULL
method	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Biochemicals	NULL
Inc.	NULL
,	NULL
Indi-anapolis	NULL
,	NULL
Indiana	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

An	NULL
end-labeled	NULL
oligonucleotide	NULL
specific	NULL
for	NULL
188	NULL
mRNA	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
variations	NULL
in	NULL
loading	NULL
,	NULL
as	NULL
described	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|	NULL
Number4	NULL
Figure	NULL
1	NULL
RAW	NULL
264.7	NULL
cells	NULL
express	NULL
functional	NULL
ERs	NULL
and	NULL
mRNA	NULL
for	NULL
ERQ	NULL
and	NULL
ERR	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
that	NULL
contained	NULL
a	NULL
CAT	NULL
gene	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
an	NULL
ERE	NULL
driven	NULL
by	NULL
an	NULL
SV-40	NULL
promoter	NULL
,	NULL
and	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
E	NULL
;	NULL
or	NULL
control	NULL
vehicle	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
to	NULL
correct	NULL
for	NULL
variability	NULL
in	NULL
transfection	NULL
efficiency	NULL
and	NULL
expressed	NULL
as	NULL
normalized	NULL
CAT	NULL
activity	NULL
.	NULL

Mean	NULL
+	NULL
SEM	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
vs.	NULL
untreated	NULL
cells	NULL
.	NULL

(	NULL
b	NULL
)	NULL
RT-PCR	NULL
amplification	NULL
products	NULL
of	NULL
ERQ	NULL
and	NULL
ERB	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
reverse	NULL
transcribed	NULL
.	NULL

The	NULL
resulting	NULL
cDNA	NULL
was	NULL
amplified	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
ERQ	NULL
and	NULL
ERB	NULL
.	NULL

Two	NULL
amplification	NULL
products	NULL
corresponding	NULL
to	NULL
ER	NULL
@	NULL
and	NULL
ERB	NULL
were	NULL
detected	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
agarose	NULL
gels	NULL
.	NULL

Amplification	NULL
of	NULL
purified	NULL
mRNA	NULL
with	NULL
ERQ	NULL
and	NULL
ERB	NULL
primers	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
RT	NULL
generated	NULL
no	NULL
detectable	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Extraction	NULL
of	NULL
nuclear	NULL
protein	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

To	NULL
investigate	NULL
which	NULL
member	NULL
of	NULL
AP-1	NULL
protein	NULL
binds	NULL
to	NULL
the	NULL
TRE	NULL
sequence	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
control-	NULL
and	NULL
Ep-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
prepared	NULL
from	NULL
cells	NULL
either	NULL
stimulated	NULL
or	NULL
unstimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
(	NULL
5	NULL
ng/mL	NULL
each	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
,	NULL
using	NULL
a	NULL
method	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
double-stranded	NULL
probe	NULL
(	NULL
5-AAAGCAGCAGCCTGAGCT-CATGATCA-3	NULL
'	NULL
)	NULL
synthesized	NULL
to	NULL
represent	NULL
the	NULL
TRE	NULL
sequence	NULL
(	NULL
underlined	NULL
)	NULL
in	NULL
the	NULL
murine	NULL
TNF	NULL
promoter	NULL
(	NULL
26	NULL
mer	NULL
-686	NULL
to	NULL
-712	NULL
nucleotide	NULL
)	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
annealed	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extract	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
minutes	NULL
before	NULL
separation	NULL
of	NULL
the	NULL
DNA/protein	NULL
complexes	NULL
on	NULL
4	NULL
%	NULL
nondenaturing	NULL
PAGE	NULL
gels	NULL
,	NULL
prerun	NULL
for	NULL
1	NULL
hour	NULL
in	NULL
0.25	NULL
%	NULL
TBE	NULL
running	NULL
buffer	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
for	NULL
the	NULL
appropriate	NULL
length	NULL
of	NULL
time	NULL
.	NULL

For	NULL
band	NULL
supershifting	NULL
,	NULL
200	NULL
ng	NULL
of	NULL
the	NULL
appropriate	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
on	NULL
ice	NULL
40	NULL
minutes	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Immunoprecipitations	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Immunoprecipitation	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Jain	NULL
et	NULL
al	NULL
.	NULL

(	NULL
42	NULL
)	NULL
,	NULL
with	NULL
modifications	NULL
(	NULL
41	NULL
)	NULL
using	NULL
polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
all	NULL
members	NULL
of	NULL
either	NULL
the	NULL
Jun	NULL
or	NULL
Fos	NULL
families	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

For	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
mAb	NULL
's	NULL
specific	NULL
for	NULL
c-Jun	NULL
,	NULL
JunD	NULL
,	NULL
or	NULL
JunB	NULL
.	NULL

Western	NULL
blots	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Towbin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
43	NULL
)	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
Jun	NULL
proteins	NULL
,	NULL
Fos	NULL
proteins	NULL
,	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
or	NULL
JunD	NULL
,	NULL
as	NULL
appropriate	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
Ez	NULL
on	NULL
the	NULL
levels	NULL
of	NULL
total	NULL
(	NULL
dephosphorylated	NULL
+	NULL
phosphorylated	NULL
)	NULL
JNK	NULL
and	NULL
active	NULL
(	NULL
phosphorylated	NULL
)	NULL
JNK	NULL
,	NULL
whole-cell	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
control-	NULL
and	NULL
Ep-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
either	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

Cell	NULL
lysates	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
were	NULL
resolved	NULL
on	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
gels	NULL
and	NULL
transblotted	NULL
onto	NULL
nitrocellulose	NULL
.	NULL

Total	NULL
and	NULL
phos-	NULL
o	NULL
y	NULL
cti	NULL
1500	NULL
1000	NULL
Noemalized	NULL
CAT	NULL
as	NULL
cn	NULL
tu	NULL
*	NULL
Rio	NULL
IE	NULL
FP-JC	NULL
'	NULL
M\	NULL
RAW	NULL
264.7	NULL
cells	NULL
Positive	NULL
controls	NULL
Eis	NULL
ERJ	NULL
891	NULL
bp	NULL
587	NULL
bp	NULL
phorylated	NULL
JNK	NULL
were	NULL
detected	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
either	NULL
total	NULL
JNK	NULL
or	NULL
phosphorylated	NULL
JNK	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
California	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescent	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Piscataway	NULL
,	NULL
New	NULL
Jersey	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

JNK	NULL
activity	NULL
assay	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
E	NULL
;	NULL
or	NULL
control	NULL
substances	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
1	NULL
hour	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8	NULL
]	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
vol/vol	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
pg/mL	NULL
leupeptin	NULL
,	NULL
2	NULL
mM	NULL
Na	NULL
;	NULL
VO4	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
as	NULL
described	NULL
(	NULL
44	NULL
)	NULL
.	NULL

JNK	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
cell	NULL
extracts	NULL
precleared	NULL
with	NULL
10-15	NULL
L	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
.	NULL

The	NULL
resin	NULL
was	NULL
then	NULL
removed	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
anti-JNK	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
immuno-complexes	NULL
were	NULL
then	NULL
precipitated	NULL
using	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
finally	NULL
washed	NULL
twice	NULL
with	NULL
kinase	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
25mM	NULL
B-glycerophosphate	NULL
,	NULL
25	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
0.1	NULL
mM	NULL
NasVO4	NULL
)	NULL
.	NULL

Beads	NULL
were	NULL
resuspended	NULL
in	NULL
25	NULL
pL	NULL
of	NULL
kinase	NULL
buffer	NULL
containing	NULL
50	NULL
uM	NULL
ATP	NULL
and	NULL
5	NULL
Ci	NULL
[	NULL
y-*P|ATP	NULL
,	NULL
and	NULL
were	NULL
incubated	NULL
for	NULL
25	NULL
minutes	NULL
at	NULL
30°C	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
recombinant	NULL
Jun	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
boiled	NULL
in	NULL
Laemmli	NULL
loading	NULL
dye	NULL
and	NULL
resolved	NULL
by	NULL
12	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

Phosphorylated	NULL
c-Jun-GST	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
autoradiography	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Statistical	NULL
analysis	NULL
.	NULL

Group	NULL
mean	NULL
values	NULL
were	NULL
compared	NULL
by	NULL
2-tailed	NULL
Student	NULL
's	NULL
¢	NULL
test	NULL
or	NULL
1-way	NULL
ANOVA	NULL
,	NULL
as	NULL
appropriate	NULL
.	NULL

Subsequent	NULL
mean	NULL
comparison	NULL
tests	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
Fisher	NULL
protected	NULL
least	NULL
significant	NULL
difference	NULL
test	NULL
.	NULL

Results	NULL
RAW	NULL
264.7	NULL
cells	NULL
express	NULL
functional	NULL
ERs	NULL
and	NULL
mRNA	NULL
for	NULL
both	NULL
ERa	NULL
and	NULL
ERB	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
a	NULL
murine	NULL
monocytic	NULL
line	NULL
known	NULL
to	NULL
produce	NULL
TNF	NULL
in	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|_	NULL
Number	NULL
4	NULL
505	NULL
al	NULL
R	NULL
tso	NULL
100	NULL
,	NULL
9	NULL
E	NULL
;	NULL
,	NULL
(	NULL
10	NULL
®	NULL
mp	NULL
In	NULL
E	NULL
Ta-	NULL
$	NULL
5	NULL
x	NULL
§0-	NULL
&	NULL
£	NULL
&	NULL
25-|_	NULL
o-	NULL
Iss	NULL
IL-1	NULL
+	NULL
TNF	NULL
No	NULL
E	NULL
,	NULL
EEH	NULL
'D	NULL
'	NULL
E	NULL
'M	NULL
}	NULL
TNC	NULL
:	NULL
UKR	NULL
ss	NULL
185	NULL
IL-1	NULL
+	NULL
TNF	NULL
Figure	NULL
2	NULL
In	NULL
vitro	NULL
E	NULL
;	NULL
treatment	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
decreases	NULL
IL-1-	NULL
and	NULL
TNF-induced	NULL
production	NULL
of	NULL
TNF	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Levels	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
4	NULL
experiments	NULL
)	NULL
of	NULL
TNF	NULL
in	NULL
the	NULL
culture	NULL
medium	NULL
as	NULL
assayed	NULL
by	NULL
an	NULL
ELISA	NULL
specific	NULL
for	NULL
murine	NULL
TNF	NULL
.	NULL

Equal	NULL
numbers	NULL
of	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
murine	NULL
IL-1	NULL
and	NULL
human	NULL
TNF	NULL
(	NULL
5	NULL
ng/mL	NULL
of	NULL
each	NULL
)	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
either	NULL
control	NULL
vehicle	NULL
or	NULL
E	NULL
,	NULL
(	NULL
10~®M	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
vs.	NULL
untreated	NULL
cells	NULL
.	NULL

(	NULL
b	NULL
)	NULL
TNF	NULL
mRNA	NULL
expression	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
control	NULL
vehicle	NULL
or	NULL
E	NULL
;	NULL
(	NULL
10®M	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
(	NULL
5	NULL
ng/mL	NULL
of	NULL
each	NULL
)	NULL
during	NULL
the	NULL
last	NULL
4	NULL
hours	NULL
of	NULL
incuba-tion	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
replicate	NULL
experiments	NULL
.	NULL

506	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
(	NULL
47	NULL
)	NULL
,	NULL
express	NULL
functional	NULL
ERs	NULL
,	NULL
transient	NULL
transfection	NULL
experiments	NULL
were	NULL
conducted	NULL
using	NULL
a	NULL
reporter	NULL
plasmid	NULL
that	NULL
contained	NULL
a	NULL
CAT	NULL
gene	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
an	NULL
ERE	NULL
driven	NULL
by	NULL
an	NULL
SV-40	NULL
promoter	NULL
.	NULL

Three	NULL
replicate	NULL
experiments	NULL
revealed	NULL
that	NULL
24-hour	NULL
E	NULL
;	NULL
(	NULL
10°	NULL
M	NULL
)	NULL
treatment	NULL
increases	NULL
CAT	NULL
activity	NULL
6-fold	NULL
(	NULL
Figure	NULL
1a	NULL
)	NULL
,	NULL
thus	NULL
demonstrating	NULL
that	NULL
RAW	NULL
264.7	NULL
cells	NULL
express	NULL
functional	NULL
ER	NULL
.	NULL

Because	NULL
this	NULL
assay	NULL
does	NULL
not	NULL
provide	NULL
information	NULL
as	NULL
to	NULL
whether	NULL
RAW	NULL
264.7	NULL
cells	NULL
express	NULL
ERG	NULL
,	NULL
ERB	NULL
,	NULL
or	NULL
both	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
reverse	NULL
transcribed	NULL
.	NULL

The	NULL
resulting	NULL
cDNA	NULL
was	NULL
then	NULL
amplified	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
ERQ	NULL
or	NULL
ERB	NULL
.	NULL

Two	NULL
amplification	NULL
products	NULL
corresponding	NULL
to	NULL
ERQ	NULL
and	NULL
ERB	NULL
were	NULL
detected	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
an	NULL
agarose	NULL
gel	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
.	NULL

E	NULL
;	NULL
decreases	NULL
the	NULL
IL-1-	NULL
and	NULL
TNF-induced	NULL
production	NULL
of	NULL
TNF	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Having	NULL
determined	NULL
that	NULL
RAW	NULL
264.7	NULL
cells	NULL
respond	NULL
to	NULL
E	NULL
;	NULL
and	NULL
express	NULL
functional	NULL
ERs	NULL
and	NULL
mRNA	NULL
for	NULL
ERQ	NULL
and	NULL
ERB	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
,	NULL
on	NULL
the	NULL
production	NULL
of	NULL
TNF	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

Preliminary	NULL
studies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
revealed	NULL
that	NULL
combined	NULL
stimulation	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
(	NULL
5	NULL
ng/mL	NULL
of	NULL
each	NULL
)	NULL
induces	NULL
the	NULL
secretion	NULL
of	NULL
2.2-fold-higher	NULL
levels	NULL
of	NULL
TNF	NULL
into	NULL
the	NULL
culture	NULL
medium	NULL
than	NULL
does	NULL
treatment	NULL
with	NULL
either	NULL
IL-1	NULL
or	NULL
TNF	NULL
alone	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
investigate	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
in	NULL
conditions	NULL
of	NULL
maximal	NULL
TNF	NULL
production	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
(	NULL
5	NULL
ng/mL	NULL
of	NULL
each	NULL
)	NULL
and	NULL
treated	NULL
with	NULL
either	NULL
ethanol	NULL
(	NULL
control	NULL
vehicle	NULL
)	NULL
or	NULL
10°	NULL
M	NULL
E	NULL
;	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
culture	NULL
medium	NULL
was	NULL
then	NULL
assayed	NULL
by	NULL
an	NULL
ELISA	NULL
specific	NULL
for	NULL
murine	NULL
TNF	NULL
.	NULL

Four	NULL
replicate	NULL
experiments	NULL
revealed	NULL
that	NULL
the	NULL
level	NULL
of	NULL
murine	NULL
TNF	NULL
was	NULL
approximately	NULL
3-fold	NULL
lower	NULL
in	NULL
medium	NULL
from	NULL
Ep-treated	NULL
cells	NULL
than	NULL
in	NULL
medium	NULL
from	NULL
controls	NULL
(	NULL
Figure	NULL
2a	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
E	NULL
;	NULL
,	NULL
regulates	NULL
TNF	NULL
mRNA	NULL
expression	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
and	NULL
treated	NULL
with	NULL
E	NULL
»	NULL
(	NULL
10°	NULL
M	NULL
)	NULL
as	NULL
already	NULL
described	NULL
here	NULL
.	NULL

The	NULL
steady-state	NULL
expression	NULL
of	NULL
TNF	NULL
mRNA	NULL
was	NULL
then	NULL
assessed	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Data	NULL
from	NULL
1	NULL
representative	NULL
experiment	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
2b	NULL
.	NULL

Hybridized	NULL
TNF	NULL
mRNA	NULL
and	NULL
188	NULL
mRNA	NULL
were	NULL
quantified	NULL
by	NULL
densitometry	NULL
.	NULL

The	NULL
relative	NULL
density	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
expressed	NULL
as	NULL
TNF/18S	NULL
mRNA	NULL
density	NULL
ratio	NULL
.	NULL

Triplicate	NULL
experiments	NULL
revealed	NULL
that	NULL
E	NULL
;	NULL
decreases	NULL
TNF	NULL
mRNA	NULL
levels	NULL
by	NULL
approximately	NULL
3-fold	NULL
in	NULL
cytokine-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
that	NULL
E	NULL
;	NULL
regulates	NULL
the	NULL
signaling	NULL
pathway	NULL
that	NULL
leads	NULL
to	NULL
TNF	NULL
production	NULL
in	NULL
response	NULL
to	NULL
cytokine	NULL
stimulation	NULL
.	NULL

E	NULL
;	NULL
decreases	NULL
TNF	NULL
gene	NULL
expression	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
effects	NULL
of	NULL
E	NULL
,	NULL
on	NULL
TNF	NULL
gene	NULL
expression	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
E	NULL
,	NULL
(	NULL
10	NULL
to	NULL
102	NULL
M	NULL
)	NULL
or	NULL
control	NULL
vehicle	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
plus	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3/UTR	NULL
(	NULL
a	NULL
message	NULL
stability	NULL
and	NULL
translation	NULL
regulating	NULL
sequence	NULL
)	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
and	NULL
either	NULL
E	NULL
;	NULL
(	NULL
107	NULL
to	NULL
10-2	NULL
M	NULL
)	NULL
or	NULL
control	NULL
vehicle	NULL
for	NULL
12	NULL
hours	NULL
.	NULL

Cytoso-lic	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
weak	NULL
in	NULL
basal	NULL
conditions	NULL
,	NULL
but	NULL
it	NULL
was	NULL
increased	NULL
by	NULL
about	NULL
14-fold	NULL
after	NULL
stimulation	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
treatment	NULL
with	NULL
E	NULL
;	NULL
decreased	NULL
IL-1-	NULL
and	NULL
TNF-induced	NULL
TNF	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Figure	NULL
3	NULL
,	NULL
filled	NULL
bars	NULL
)	NULL
.	NULL

The	NULL
largest	NULL
inhibition	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
~3.5-fold	NULL
)	NULL
was	NULL
obtained	NULL
with	NULL
an	NULL
E	NULL
;	NULL
dose	NULL
equal	NULL
to	NULL
107	NULL
M.	NULL
Time	NULL
course	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
demonstrated	NULL
no	NULL
inhibitory	NULL
effects	NULL
of	NULL
Ez	NULL
for	NULL
treatment	NULL
periods	NULL
up	NULL
to	NULL
2	NULL
hours	NULL
.	NULL

Maximal	NULL
inhibitory	NULL
activity	NULL
was	NULL
observed	NULL
at	NULL
24	NULL
hours	NULL
.	NULL

Treatment	NULL
with	NULL
E	NULL
;	NULL
for	NULL
48	NULL
hours	NULL
resulted	NULL
in	NULL
no	NULL
additional	NULL
inhibition	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

When	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
and	NULL
cotransfected	NULL
with	NULL
a	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
lacking	NULL
the	NULL
3	NULL
``	NULL
UTR	NULL
region	NULL
,	NULL
an	NULL
identical	NULL
inhibitory	NULL
effect	NULL
of	NULL
E	NULL
,	NULL
on	NULL
CAT	NULL
activity	NULL
was	NULL
demonstrated	NULL
(	NULL
Figure	NULL
3	NULL
,	NULL
open	NULL
bars	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
3	NULL
``	NULL
UTR	NULL
region	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
regulates	NULL
message	NULL
stability	NULL
and	NULL
its	NULL
translation	NULL
(	NULL
29	NULL
)	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
E	NULL
;	NULL
modulates	NULL
cytokine-induced	NULL
TNF	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
Ez	NULL
on	NULL
TNF	NULL
gene	NULL
expression	NULL
are	NULL
mediated	NULL
by	NULL
ERP	NULL
.	NULL

Because	NULL
RAW	NULL
264.7	NULL
cells	NULL
express	NULL
endoge-nous	NULL
ERs	NULL
,	NULL
they	NULL
are	NULL
not	NULL
suitable	NULL
for	NULL
investigating	NULL
the	NULL
contribution	NULL
of	NULL
a	NULL
specific	NULL
ER	NULL
phenotype	NULL
to	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
E	NULL
,	NULL
on	NULL
TNF	NULL
gene	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
on	NULL
TNF	NULL
gene	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|	NULL
_	NULL
Number4	NULL
Figure	NULL
3	NULL
E	NULL
;	NULL
decreases	NULL
TNF	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Raw	NULL
264.7	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
E	NULL
;	NULL
(	NULL
107	NULL
to	NULL
10-2	NULL
M	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
before	NULL
transfection	NULL
and	NULL
then	NULL
transiently	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
plus	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3	NULL
``	NULL
UTR	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
or	NULL
a	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
lacking	NULL
the	NULL
3	NULL
``	NULL
UTR	NULL
region	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
treated	NULL
again	NULL
with	NULL
E	NULL
;	NULL
(	NULL
107-1072	NULL
M	NULL
)	NULL
and	NULL
5	NULL
ng	NULL
of	NULL
TNF	NULL
and	NULL
IL-1	NULL
for	NULL
12	NULL
hours	NULL
.	NULL

Mean	NULL
+	NULL
SEM	NULL
of	NULL
4	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
vs.	NULL
untreated	NULL
cells	NULL
.	NULL

expression	NULL
are	NULL
mediated	NULL
by	NULL
ERQ	NULL
,	NULL
ERB	NULL
,	NULL
or	NULL
both	NULL
,	NULL
experiments	NULL
were	NULL
conducted	NULL
using	NULL
HeLa	NULL
cells	NULL
,	NULL
an	NULL
ER-negative	NULL
line	NULL
that	NULL
,	NULL
once	NULL
transfected	NULL
with	NULL
ERs	NULL
,	NULL
exhibits	NULL
a	NULL
response	NULL
to	NULL
E	NULL
;	NULL
similar	NULL
to	NULL
the	NULL
responses	NULL
of	NULL
natural	NULL
E	NULL
;	NULL
target	NULL
cells	NULL
(	NULL
48	NULL
)	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
transiently	NULL
cotransfected	NULL
with	NULL
the	NULL
TNE/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
plus	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3'UTR	NULL
already	NULL
described	NULL
here	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
and	NULL
either	NULL
ERG	NULL
or	NULL
ERP	NULL
expression	NULL
vectors	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
either	NULL
E	NULL
,	NULL
(	NULL
10°	NULL
M	NULL
)	NULL
or	NULL
control	NULL
vehicle	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
stimulated	NULL
with	NULL
5	NULL
ng	NULL
each	NULL
of	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
12	NULL
hours	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
transfected	NULL
cells	NULL
express	NULL
functional	NULL
ERs	NULL
,	NULL
parallel	NULL
control	NULL
experiments	NULL
were	NULL
conducted	NULL
in	NULL
which	NULL
HeLa	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
ERQ	NULL
or	NULL
ERB	NULL
expression	NULL
vector	NULL
and	NULL
an	NULL
ERE/luciferase	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
a	NULL
minimal	NULL
promoter	NULL
.	NULL

E	NULL
;	NULL
,	NULL
significantly	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
increased	NULL
ERE	NULL
luciferase	NULL
activity	NULL
,	NULL
both	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
ER	NULL
&	NULL
and	NULL
in	NULL
those	NULL
transfected	NULL
with	NULL
ERB	NULL
expression	NULL
vector	NULL
(	NULL
Figure	NULL
4a	NULL
)	NULL
,	NULL
thus	NULL
demonstrating	NULL
that	NULL
transfected	NULL
HeLa	NULL
cells	NULL
express	NULL
functional	NULL
ER	NULL
.	NULL

Moreover	NULL
,	NULL
E	NULL
,	NULL
decreased	NULL
TNF/CAT	NULL
activity	NULL
in	NULL
cells	NULL
expressing	NULL
ERB	NULL
,	NULL
whereas	NULL
it	NULL
had	NULL
no	NULL
effect	NULL
in	NULL
those	NULL
expressing	NULL
ER	NULL
&	NULL
(	NULL
Figure	NULL
4b	NULL
)	NULL
,	NULL
thus	NULL
demonstrating	NULL
that	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
E	NULL
;	NULL
on	NULL
TNF	NULL
gene	NULL
expression	NULL
is	NULL
specifically	NULL
mediated	NULL
by	NULL
ERB	NULL
.	NULL

E	NULL
,	NULL
downregulates	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
decreasing	NULL
the	NULL
binding	NULL
of	NULL
AP-1	NULL
proteins	NULL
to	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
IL-1	NULL
+	NULL
TNF	NULL
stimulation	NULL
0000-	NULL
M	NULL
5	NULL
!	NULL

-3	NULL
'	NULL
TNF/CAT	NULL
construct	NULL
25000	NULL
-	NULL
C	NULL
5°	NULL
TNE/CAT	NULL
construct	NULL
20000	NULL
-15p00-	NULL
10000-	NULL
Normalized	NULL
CAT	NULL
activity	NULL
Unstimulated	NULL
cells	NULL
5000	NULL
10°	NULL
10	NULL
%	NULL
107	NULL
1042	NULL
ao	NULL
!	NULL
``	NULL

1019	NULL
Estrogen	NULL
dose	NULL
(	NULL
M	NULL
)	NULL
of	NULL
E	NULL
,	NULL
on	NULL
TNF	NULL
promoter	NULL
activity	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
indirect	NULL
,	NULL
because	NULL
there	NULL
is	NULL
no	NULL
typical	NULL
ERE	NULL
sequence	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
because	NULL
AP-1	NULL
is	NULL
activated	NULL
by	NULL
IL-1	NULL
and	NULL
TNF	NULL
,	NULL
E	NULL
;	NULL
,	NULL
may	NULL
repress	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
blocking	NULL
AP-1	NULL
binding	NULL
to	NULL
TNF	NULL
promoter	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
hypoth-esis	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
the	NULL
functional	NULL
role	NULL
of	NULL
the	NULL
TRE	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
corresponding	NULL
to	NULL
the	NULL
full	NULL
TNF	NULL
promoter	NULL
(	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
)	NULL
plus	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3/UTR	NULL
,	NULL
containing	NULL
point	NULL
mutations	NULL
of	NULL
the	NULL
TRE	NULL
site	NULL
that	NULL
were	NULL
reported	NULL
previously	NULL
to	NULL
reduce	NULL
TNF	NULL
promoter	NULL
activity	NULL
(	NULL
27	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
TRE	NULL
site	NULL
reduced	NULL
IL-1-	NULL
and	NULL
TNF-induced	NULL
CAT	NULL
activity	NULL
4-fold	NULL
,	NULL
whereas	NULL
it	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
1	NULL
ug/mL	NULL
)	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
TRE	NULL
site	NULL
is	NULL
required	NULL
for	NULL
cytokines	NULL
to	NULL
induce	NULL
TNF	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
abolishes	NULL
the	NULL
ability	NULL
of	NULL
Ez	NULL
to	NULL
block	NULL
IL-1-	NULL
and	NULL
TNF-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
,	NULL
additional	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
control-	NULL
and	NULL
E	NULL
;	NULL
-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
was	NULL
low	NULL
in	NULL
both	NULL
untreated	NULL
and	NULL
E	NULL
;	NULL
-treated	NULL
IL-1-	NULL
and	NULL
TNF-stimulated	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
AP-1	NULL
mutant	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
experiments	NULL
did	NULL
not	NULL
allow	NULL
us	NULL
to	NULL
determine	NULL
conclusively	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
abrogates	NULL
the	NULL
repressive	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
,	NULL
on	NULL
TNF	NULL
gene	NULL
expression	NULL
.	NULL

a	NULL
g	NULL
124	NULL
ERo	NULL
:	NULL
12	NULL
,	NULL
ERB	NULL
T	NULL
§	NULL
-	NULL
10-	NULL
10-	NULL
~	NULL
Poa	NULL
s	NULL
Sg	NULL
Figure	NULL
4	NULL
3	NULL
s-	NULL
6-	NULL
\	NULL
ERB	NULL
specifically	NULL
mediates	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
E	NULL
;	NULL
on	NULL
TNF	NULL
gene	NULL
expres-	NULL
i	NULL
\	NULL
sion	NULL
.	NULL

(	NULL
a	NULL
)	NULL
HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
reporter	NULL
plasmid	NULL
that	NULL
con-	NULL
8a	NULL
*	NULL
4+	NULL
\	NULL
tained	NULL
a	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
an	NULL
ERE	NULL
g	NULL
2-	NULL
2j	NULL
*	NULL
driven	NULL
by	NULL
a	NULL
minimal	NULL
promoter	NULL
,	NULL
and	NULL
treated	NULL
with	NULL
either	NULL
E	NULL
;	NULL
or	NULL
control	NULL
3	NULL
0_-—	NULL
|	NULL
0	NULL
;	NULL
S	NULL
‘	NULL
R	NULL
‘	NULL
k	NULL
;	NULL
vehicle	NULL
as	NULL
described	NULL
for	NULL
the	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
b	NULL
No	NULL
Ep	NULL
Ep	NULL
normalized	NULL
to	NULL
ﬁ-galactosidase	NULL
activity	NULL
to	NULL
correct	NULL
for	NULL
variability	NULL
in	NULL
trans-	NULL
75000-	NULL
20000-fection	NULL
efficiency	NULL
and	NULL
expressed	NULL
as	NULL
normalized	NULL
luciferase	NULL
activity	NULL
.	NULL

Mean	NULL
g	NULL
”	NULL
``	NULL
+	NULL
SEM	NULL
from	NULL
1	NULL
representative	NULL
experiment	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
vs.	NULL
untreated	NULL
cells	NULL
.	NULL

a	NULL
}	NULL
(	NULL
b	NULL
)	NULL
HeLa	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
E	NULL
;	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
and	NULL
cotransfected	NULL
g	NULL
50000	NULL
with	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5°	NULL
promoter	NULL
region	NULL
plus	NULL
2	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3'UTR	NULL
and	NULL
either	NULL
ERQ	NULL
or	NULL
ERB	NULL
expression	NULL
vectors	NULL
.	NULL

Cells	NULL
were	NULL
é	NULL
25000-then	NULL
treated	NULL
with	NULL
E	NULL
;	NULL
and	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
12	NULL
hours	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
€	NULL
text	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
subsequently	NULL
lysed	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
and	NULL
B-	NULL
3	NULL
galactosidase	NULL
activities	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

Mean	NULL
+	NULL
SEM	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
vs.	NULL
untreated	NULL
cells	NULL
.	NULL

No	NULL
Ep	NULL
Ep	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August1999	NULL
|	NULL
Volume104	NULL
|	NULL
Number4	NULL
507	NULL
Normalized	NULL
CAT	NULL
activity	NULL
IL~1	NULL
TNF	NULL
R	NULL
TNE/CAT	NULL
construct	NULL
[	NULL
_	NULL
]	NULL
AP-1	NULL
mutated	NULL
TNF/CAT	NULL
construct	NULL
LPS	NULL
Unstimulated	NULL
cells	NULL
Figure	NULL
5	NULL
IL-1	NULL
and	NULL
TNF	NULL
induce	NULL
TNF	NULL
gene	NULL
expression	NULL
via	NULL
the	NULL
TRE	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

Raw	NULL
264.7	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
wild-type	NULL
TNF/CAT	NULL
construct	NULL
containing	NULL
the	NULL
2.2-kb	NULL
5	NULL
``	NULL
promoter	NULL
region	NULL
plus	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
3'UTR	NULL
or	NULL
the	NULL
corresponding	NULL
plasmid	NULL
with	NULL
a	NULL
site-directed	NULL
mutation	NULL
of	NULL
the	NULL
TRE	NULL
site	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
either	NULL
IL-1	NULL
+	NULL
TNF	NULL
or	NULL
LPS	NULL
for	NULL
12	NULL
hours	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
to	NULL
correct	NULL
for	NULL
variability	NULL
in	NULL
transfection	NULL
efficiency	NULL
and	NULL
expressed	NULL
as	NULL
normalized	NULL
CAT	NULL
activity	NULL
.	NULL

Mean	NULL
+	NULL
SEM	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
vs.	NULL
unstimulated	NULL
cells	NULL
.	NULL

**P	NULL
<	NULL
0.01	NULL
vs.	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
TNF/CAT	NULL
reporter	NULL
gene	NULL
construct	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
the	NULL
hypothesis	NULL
that	NULL
E	NULL
,	NULL
specifically	NULL
inhibits	NULL
AP-1-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
,	NULL
RAW	NULL
267.4	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
and	NULL
without	NULL
E	NULL
;	NULL
(	NULL
10°	NULL
M	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
1-hour	NULL
stimulation	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
.	NULL

EMSAs	NULL
were	NULL
then	NULL
conducted	NULL
by	NULL
incubating	NULL
nuclear	NULL
extracts	NULL
from	NULL
control-	NULL
and	NULL
E	NULL
;	NULL
-treated	NULL
cells	NULL
with	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
TNF	NULL
promoter	NULL
containing	NULL
the	NULL
TRE	NULL
site	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
,	NULL
these	NULL
studies	NULL
revealed	NULL
that	NULL
samples	NULL
from	NULL
both	NULL
control-	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
Ep-treated	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
cells	NULL
generate	NULL
a	NULL
single	NULL
complex	NULL
,	NULL
which	NULL
was	NULL
confirmed	NULL
as	NULL
AP-1	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
50-fold	NULL
M	NULL
excess	NULL
TRE	NULL
consensus	NULL
oligonucleotide	NULL
to	NULL
displace	NULL
the	NULL
complex	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Three	NULL
such	NULL
replicate	NULL
experiments	NULL
revealed	NULL
that	NULL
Ez	NULL
decreases	NULL
the	NULL
binding	NULL
of	NULL
AP-1	NULL
to	NULL
the	NULL
TRE	NULL
motif	NULL
by	NULL
approximately	NULL
3-fold	NULL
.	NULL

Figure	NULL
6	NULL
E	NULL
;	NULL
decreases	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
,	NULL
whereas	NULL
it	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
of	NULL
NF-KB	NULL
and	NULL
Sp-1	NULL
to	NULL
their	NULL
consensus	NULL
sequences	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
nuclear	NULL
extracts	NULL
of	NULL
untreated	NULL
and	NULL
Ep-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
1	NULL
hour	NULL
with	NULL
P-labeled	NULL
probes	NULL
containing	NULL
the	NULL
TRE	NULL
,	NULL
the	NULL
NF-KB	NULL
,	NULL
or	NULL
the	NULL
Sp-1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

Gel	NULL
shift	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
To	NULL
demonstrate	NULL
specificity	NULL
,	NULL
additional	NULL
EMSAs	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
as	NULL
probes	NULL
sequences	NULL
corresponding	NULL
to	NULL
the	NULL
4	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
factor-kB	NULL
(	NULL
NF-KB	NULL
)	NULL
and	NULL
the	NULL
1	NULL
binding	NULL
site	NULL
for	NULL
Sp-1	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
inability	NULL
of	NULL
E	NULL
,	NULL
to	NULL
repress	NULL
LPS-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
found	NULL
that	NULL
E	NULL
;	NULL
does	NULL
not	NULL
downregulate	NULL
the	NULL
binding	NULL
of	NULL
NF-KB	NULL
to	NULL
the	NULL
NF-KB1	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
or	NULL
to	NULL
the	NULL
NF-KB2	NULL
,	NULL
NF-KB3	NULL
,	NULL
and	NULL
NF-KB4	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
consensus	NULL
sequences	NULL
.	NULL

Further	NULL
attesting	NULL
to	NULL
specificity	NULL
,	NULL
E	NULL
,	NULL
did	NULL
not	NULL
block	NULL
Sp-1	NULL
binding	NULL
to	NULL
its	NULL
binding	NULL
site	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
observations	NULL
indicate	NULL
that	NULL
E	NULL
,	NULL
downregulates	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
decreasing	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

Because	NULL
Ez	NULL
decreases	NULL
,	NULL
but	NULL
does	NULL
not	NULL
completely	NULL
block	NULL
,	NULL
TNF	NULL
gene	NULL
expression	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
TNF	NULL
transcription	NULL
enhancers	NULL
such	NULL
as	NULL
NF-KB	NULL
account	NULL
for	NULL
the	NULL
residual	NULL
TNF	NULL
gene	NULL
expression	NULL
observed	NULL
in	NULL
E-treated	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
proteins	NULL
form	NULL
the	NULL
AP-1	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
TNF	NULL
promoter	NULL
of	NULL
cytokine-stimulated	NULL
RAW	NULL
267.4	NULL
cells	NULL
,	NULL
EMSAs	NULL
were	NULL
conducted	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
of	NULL
proteins	NULL
.	NULL

An	NULL
anti-Fos	NULL
antibody	NULL
that	NULL
cross-reacts	NULL
with	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
family	NULL
of	NULL
proteins	NULL
supershifted	NULL
the	NULL
band	NULL
,	NULL
as	NULL
viewed	NULL
with	NULL
P-labeled	NULL
AP-1	NULL
probe	NULL
in	NULL
both	NULL
control-	NULL
and	NULL
E-treated	NULL
cells	NULL
(	NULL
Figure	NULL
7a	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
an	NULL
anti-Jun	NULL
antibody	NULL
that	NULL
cross-reacts	NULL
with	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
family	NULL
of	NULL
proteins	NULL
caused	NULL
the	NULL
disap-	NULL
pearance	NULL
of	NULL
the	NULL
complex	NULL
in	NULL
control-	NULL
and	NULL
E-treated	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
AP-1	NULL
complex	NULL
was	NULL
not	NULL
supershifted	NULL
by	NULL
anti-CREB	NULL
antibody	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
Ez	NULL
decreases	NULL
the	NULL
binding	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
of	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
form	NULL
the	NULL
Jun/Fos	NULL
heterodimers	NULL
binding	NULL
to	NULL
the	NULL
TNF	NULL
promoter	NULL
,	NULL
additional	NULL
EMSAs	NULL
were	NULL
conducted	NULL
using	NULL
mAb	NULL
's	NULL
against	NULL
specific	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
.	NULL

In	NULL
untreated	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
specific	NULL
anti-c-Jun	NULL
antibody	NULL
supershifted	NULL
the	NULL
Jun	NULL
band	NULL
(	NULL
Figure	NULL
7b	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
anti-JunD	NULL
antiserum	NULL
led	NULL
to	NULL
the	NULL
almost	NULL
complete	NULL
disappearance	NULL
of	NULL
the	NULL
Jun	NULL
band	NULL
,	NULL
whereas	NULL
anti-JunB	NULL
antibody	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
in	NULL
samples	NULL
from	NULL
E	NULL
;	NULL
-treated	NULL
cells	NULL
,	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
was	NULL
less	NULL
intense	NULL
than	NULL
in	NULL
the	NULL
corresponding	NULL
samples	NULL
from	NULL
control	NULL
cells	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
anti-c-Jun	NULL
antibody	NULL
supershifted	NULL
1	NULL
2	NULL
O3	NULL
4	NULL
NF-kB	NULL
“	NULL
u	NULL
and	NULL
viewed	NULL
by	NULL
autoradiography	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
induced	NULL
complexes	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
50-fold	NULL
M	NULL
excess	NULL
of	NULL
unlabeled	NULL
specific	NULL
probe	NULL
.	NULL

Lane	NULL
1	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
control	NULL
vehicle	NULL
;	NULL
lane	NULL
2	NULL
:	NULL
cells	NULL
treated	NULL
with	NULL
E	NULL
,	NULL
(	NULL
108	NULL
M	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
:	NULL
50	NULL
%	NULL
cold	NULL
probe	NULL
;	NULL
lane	NULL
4	NULL
:	NULL
free	NULL
probe	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
replicate	NULL
experiments	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
data	NULL
from	NULL
all	NULL
experiments	NULL
revealed	NULL
that	NULL
AP-1	NULL
binding	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
was	NULL
approximately	NULL
3	NULL
fold	NULL
lower	NULL
in	NULL
Ep-treated	NULL
samples	NULL
than	NULL
in	NULL
vehicle-treated	NULL
samples	NULL
.	NULL

508	NULL
co.	NULL
luli	NULL
)	NULL
bo	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|	NULL
_	NULL
Number4	NULL
the	NULL
AP-1	NULL
band	NULL
,	NULL
whereas	NULL
the	NULL
addition	NULL
of	NULL
anti-JunD	NULL
caused	NULL
its	NULL
complete	NULL
disappearance	NULL
.	NULL

As	NULL
in	NULL
the	NULL
case	NULL
of	NULL
untreated	NULL
cells	NULL
,	NULL
antibody	NULL
against	NULL
JunB	NULL
had	NULL
no	NULL
effects	NULL
.	NULL

In	NULL
both	NULL
untreated	NULL
and	NULL
E	NULL
,	NULL
-treated	NULL
cells	NULL
,	NULL
the	NULL
AP-1	NULL
complex	NULL
was	NULL
also	NULL
supershifted	NULL
by	NULL
anti-c-Fos	NULL
antibody	NULL
(	NULL
Figure	NULL
7¢	NULL
)	NULL
,	NULL
whereas	NULL
antibodies	NULL
against	NULL
Fos-B	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
had	NULL
no	NULL
effects	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
both	NULL
untreated	NULL
and	NULL
E-treated	NULL
cells	NULL
,	NULL
the	NULL
AP-1	NULL
complex	NULL
is	NULL
formed	NULL
by	NULL
c-Jun/c-Fos	NULL
and	NULL
JunD/c-Fos	NULL
heterodimers	NULL
.	NULL

E	NULL
,	NULL
decreases	NULL
the	NULL
production	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
E	NULL
;	NULL
decreases	NULL
binding	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
,	NULL
their	NULL
nuclear	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Studies	NULL
using	NULL
polyclonal	NULL
antibodies	NULL
that	NULL
recognize	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
of	NULL
proteins	NULL
revealed	NULL
that	NULL
neither	NULL
Fos	NULL
nor	NULL
Jun	NULL
is	NULL
detectable	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
unstimulated	NULL
cells	NULL
.	NULL

Stimulation	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
resulted	NULL
in	NULL
the	NULL
production	NULL
of	NULL
both	NULL
proteins	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
data	NULL
from	NULL
3	NULL
experiments	NULL
revealed	NULL
that	NULL
E	NULL
,	NULL
decreases	NULL
the	NULL
nuclear	NULL
concentration	NULL
of	NULL
Jun	NULL
but	NULL
not	NULL
that	NULL
of	NULL
Fos	NULL
(	NULL
Figure	NULL
8a	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
E	NULL
;	NULL
decreases	NULL
the	NULL
binding	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
to	NULL
the	NULL
TNF	NULL
promoter	NULL
by	NULL
regulating	NULL
the	NULL
levels	NULL
of	NULL
Jun	NULL
.	NULL

To	NULL
characterize	NULL
further	NULL
the	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
on	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
Jun	NULL
proteins	NULL
,	NULL
Western	NULL
blot	NULL
studies	NULL
were	NULL
carried	NULL
out	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
cytokine-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
and	NULL
antibodies	NULL
specific	NULL
for	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
(	NULL
Figure	NULL
8b	NULL
)	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
data	NULL
revealed	NULL
that	NULL
E	NULL
;	NULL
decreases	NULL
the	NULL
nuclear	NULL
concentration	NULL
of	NULL
JunD	NULL
by	NULL
approximately	NULL
4-fold	NULL
and	NULL
that	NULL
of	NULL
c-Jun	NULL
by	NULL
3-fold	NULL
.	NULL

Conversely	NULL
,	NULL
E	NULL
,	NULL
had	NULL
no	NULL
effects	NULL
on	NULL
JunB	NULL
levels	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
E	NULL
;	NULL
decreases	NULL
Jun	NULL
gene	NULL
expression	NULL
,	NULL
control-	NULL
and	NULL
E-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
cJun	NULL
luciferase	NULL
construct	NULL
containing	NULL
the	NULL
full-length	NULL
c-Jun	NULL
promoter	NULL
(	NULL
49	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
revealed	NULL
that	NULL
E	NULL
;	NULL
decreases	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
construct	NULL
by	NULL
approximately	NULL
10-fold	NULL
,	NULL
thus	NULL
establishing	NULL
that	NULL
E	NULL
,	NULL
represses	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
gene	NULL
(	NULL
Figure	NULL
8c	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
demonstrate	NULL
that	NULL
E	NULL
;	NULL
blocks	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
decreasing	NULL
the	NULL
levels	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
,	NULL
a	NULL
phenomenon	NULL
that	NULL
results	NULL
in	NULL
diminished	NULL
binding	NULL
of	NULL
c-Jun/c-Fos	NULL
and	NULL
JunD/c-Fos	NULL
heterodimers	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

E	NULL
;	NULL
decreases	NULL
JNK	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

The	NULL
promoter	NULL
regions	NULL
of	NULL
both	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
genes	NULL
contain	NULL
2	NULL
TRE	NULL
sites	NULL
constitutively	NULL
occupied	NULL
by	NULL
Jun/ATF2	NULL
heterodimers	NULL
.	NULL

However	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
autoinduction	NULL
of	NULL
Jun	NULL
genes	NULL
by	NULL
Jun/ATF2	NULL
heterodimers	NULL
is	NULL
enhanced	NULL
by	NULL
JNK-induced	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
.	NULL

Ez	NULL
may	NULL
thus	NULL
downregulate	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
,	NULL
thereby	NULL
decreasing	NULL
AP-1-induced	NULL
TNF	NULL
transcription	NULL
,	NULL
by	NULL
blunting	NULL
JNK	NULL
activity	NULL
and	NULL
the	NULL
resulting	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
E	NULL
,	NULL
regulates	NULL
JNK	NULL
activity	NULL
,	NULL
RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
E	NULL
;	NULL
or	NULL
control	NULL
vehicle	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
a	NULL
length	NULL
of	NULL
time	NULL
sufficient	NULL
to	NULL
induce	NULL
genomic	NULL
effects	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
0-15	NULL
minutes	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
then	NULL
immunoprecipitated	NULL
using	NULL
an	NULL
antibody	NULL
that	NULL
recognizes	NULL
2	NULL
members	NULL
of	NULL
the	NULL
JNK	NULL
family	NULL
,	NULL
JNK1	NULL
and	NULL
JNK2	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
proteins	NULL
were	NULL
recovered	NULL
and	NULL
incubated	NULL
with	NULL
recombinant	NULL
GST-c-Jun	NULL
(	NULL
a	NULL
JNK	NULL
substrate	NULL
)	NULL
and	NULL
[	NULL
y	NULL
Eg	NULL
_-	NULL
_	NULL
$	NULL
_-	NULL
#	NULL
s	NULL
#	NULL
=	NULL
@	NULL
Fos	NULL
=	NULL
»	NULL
4	NULL
4	NULL
=	NULL
s	NULL
=	NULL
=	NULL
Jum	NULL
anfbody	NULL
|	NULL
_	NULL
L	NULL
=i	NULL
Itkin	NULL
O	NULL
(	NULL
ils	NULL
Ox	NULL
CREG	NULL
anibedy	NULL
|	NULL
.	NULL

s	NULL
s	NULL
=	NULL
<	NULL
=	NULL
-	NULL
4	NULL
+	NULL
JunB	NULL
arti	NULL
c-lun	NULL
antibody	NULL
NQ	NULL
JunD	NULL
antibody	NULL
antibody	NULL
|	NULL
Ini	NULL
E	NULL
(	NULL
10°	NULL
9m	NULL
)	NULL
had	NULL
teal	NULL
1	NULL
C	NULL
Ey	NULL
=o	NULL
ot	NULL
o-	NULL
#	NULL
-	NULL
40-40	NULL
c-Posantibody	NULL
-	NULL
-	NULL
4+	NULL
-	NULL
We	NULL
[	NULL
cla	NULL
|	NULL
tac	NULL
og	NULL
c	NULL
iD	NULL
*	NULL
&	NULL
FosBantibedy	NULL
-	NULL
\-	NULL
-	NULL
0-0	NULL
#	NULL
$	NULL
$	NULL
--	NULL
-	NULL
=	NULL
-	NULL
-	NULL
0-0-0	NULL
-o	NULL
#	NULL
0	NULL
#	NULL
0	NULL
-	NULL
>	NULL
-Fra-Zantibody	NULL
ll	NULL
-_	NULL
o	NULL
no	NULL
=	NULL
no	NULL
le	NULL
cM	NULL
Figure	NULL
7	NULL
(	NULL
a	NULL
)	NULL
E	NULL
,	NULL
decreases	NULL
the	NULL
binding	NULL
of	NULL
Fos/Jun	NULL
heterodimers	NULL
to	NULL
the	NULL
TRE	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
by	NULL
incubating	NULL
nuclear	NULL
extracts	NULL
-	NULL
from	NULL
untreated	NULL
and	NULL
Ep-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
1	NULL
hour	NULL
-	NULL
with	NULL
3°P-labeled	NULL
probes	NULL
containing	NULL
an	NULL
exact	NULL
copy	NULL
of	NULL
the	NULL
TRE	NULL
binding	NULL
site	NULL
found	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

Polyclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
,	NULL
Fos	NULL
,	NULL
and	NULL
CREB	NULL
families	NULL
of	NULL
nuclear	NULL
proteins	NULL
were	NULL
used	NULL
to	NULL
supershift	NULL
the	NULL
relevant	NULL
proteins	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
replicate	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
E	NULL
;	NULL
treatment	NULL
of	NULL
RAW	NULL
264.7	NULL
cells	NULL
decreases	NULL
the	NULL
binding	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
an	NULL
exact	NULL
copy	NULL
of	NULL
the	NULL
TRE	NULL
site	NULL
found	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
mAb	NULL
's	NULL
directed	NULL
against	NULL
c-Jun	NULL
,	NULL
JunB	NULL
,	NULL
and	NULL
JunD	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
replicate	NULL
experiments	NULL
.	NULL

(	NULL
c	NULL
)	NULL
E	NULL
;	NULL
decreases	NULL
the	NULL
binding	NULL
of	NULL
c-Fos	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
an	NULL
exact	NULL
copy	NULL
of	NULL
the	NULL
TRE	NULL
site	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
the	NULL
absence	NULL
of	NULL
mAb	NULL
's	NULL
directed	NULL
against	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
Fra-1	NULL
,	NULL
and	NULL
Fra-2	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
replicate	NULL
experiments	NULL
.	NULL

*2P|ATP	NULL
.	NULL

Phosphorylated	NULL
material	NULL
was	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
viewed	NULL
by	NULL
autoradiography	NULL
.	NULL

These	NULL
studies	NULL
revealed	NULL
that	NULL
E	NULL
;	NULL
decreases	NULL
IL-1-	NULL
and	NULL
TNF-induced	NULL
JNK	NULL
activity	NULL
by	NULL
approximately	NULL
3-fold	NULL
(	NULL
Figure	NULL
9a	NULL
)	NULL
,	NULL
with	NULL
a	NULL
peak	NULL
effect	NULL
at	NULL
5	NULL
minutes	NULL
.	NULL

Decreased	NULL
JNK	NULL
activity	NULL
may	NULL
result	NULL
from	NULL
either	NULL
lower	NULL
cell	NULL
levels	NULL
of	NULL
the	NULL
kinase	NULL
or	NULL
from	NULL
decreased	NULL
enzyme	NULL
activation	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
matter	NULL
,	NULL
Western	NULL
blot	NULL
studies	NULL
were	NULL
conducted	NULL
using	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
both	NULL
the	NULL
dephosphorylated	NULL
and	NULL
phosphorylated	NULL
species	NULL
of	NULL
JNK1	NULL
and	NULL
JNK2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
9b	NULL
,	NULL
experiments	NULL
revealed	NULL
that	NULL
E	NULL
;	NULL
,	NULL
does	NULL
not	NULL
regulate	NULL
the	NULL
levels	NULL
of	NULL
total	NULL
(	NULL
active	NULL
and	NULL
inactive	NULL
)	NULL
JNK1	NULL
and	NULL
JNK2	NULL
.	NULL

Because	NULL
JNK	NULL
is	NULL
activated	NULL
by	NULL
dual	NULL
phosphorylation	NULL
in	NULL
its	NULL
NH	NULL
>	NULL
-terminal	NULL
region	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
levels	NULL
of	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|_	NULL
Number	NULL
4	NULL
509	NULL
*	NULL
cui0°m	NULL
)	NULL
-	NULL
-	NULL
*+	NULL
IL-1	NULL
+TNF	NULL
*	NULL
+	NULL
«	NULL
~	NULL
.	NULL

.	NULL

Fas	NULL
b	NULL
Ea	NULL
{	NULL
10	NULL
°	NULL
°My	NULL
-	NULL
-	NULL
IL-1	NULL
+	NULL
TNE	NULL
-~	NULL
4	NULL
+	NULL
Jun	NULL
cami	NULL
9	NULL
~~	NULL
``	NULL
C	NULL
12,000	NULL
3	NULL
i	NULL
8	NULL
I	NULL
@	NULL
OOQ	NULL
E	NULL
B	NULL
8	NULL
C	NULL
=	NULL
2	NULL
3000-	NULL
#	NULL
R	NULL
A-Pig	NULL
é	NULL
“	NULL
;	NULL
.	NULL

Figure	NULL
8	NULL
(	NULL
a	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
carried	NULL
out	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
and	NULL
Ep-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
1	NULL
hour	NULL
and	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
all	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
families	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
replicate	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
conducted	NULL
using	NULL
antibodies	NULL
against	NULL
specific	NULL
Jun	NULL
proteins	NULL
demonstrated	NULL
that	NULL
E	NULL
;	NULL
,	NULL
downregulates	NULL
c-Jun	NULL
and	NULL
JunD	NULL
levels	NULL
,	NULL
but	NULL
not	NULL
JunB	NULL
levels	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
replicate	NULL
experiments	NULL
.	NULL

(	NULL
c	NULL
)	NULL
E	NULL
;	NULL
decreases	NULL
c-Jun	NULL
gene	NULL
expression	NULL
in	NULL
IL-1-	NULL
and	NULL
TNF-stimulated	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

Control-	NULL
and	NULL
Ep-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
a	NULL
c-Jun/luciferase	NULL
construct	NULL
containing	NULL
the	NULL
full-length	NULL
c-Jun	NULL
promoter	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
to	NULL
correct	NULL
for	NULL
variability	NULL
in	NULL
transfection	NULL
efficiency	NULL
and	NULL
expressed	NULL
as	NULL
normalized	NULL
luciferase	NULL
activity	NULL
.	NULL

Mean	NULL
+	NULL
SEM	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0.05	NULL
vs.	NULL
untreated	NULL
cells	NULL
.	NULL

phosphorylated	NULL
(	NULL
active	NULL
)	NULL
JNK	NULL
in	NULL
untreated	NULL
and	NULL
E	NULL
;	NULL
,	NULL
-treat-ed	NULL
RAW	NULL
264.7	NULL
cell	NULL
extracts	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
using	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
phosphorylated	NULL
JNK1	NULL
and	NULL
JNK2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
9¢	NULL
,	NULL
we	NULL
found	NULL
that	NULL
E	NULL
;	NULL
decreases	NULL
the	NULL
levels	NULL
of	NULL
phosphorylated	NULL
JNK	NULL
by	NULL
about	NULL
3-fold	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
that	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
E	NULL
,	NULL
decreases	NULL
the	NULL
production	NULL
of	NULL
Jun	NULL
proteins	NULL
is	NULL
by	NULL
downregulating	NULL
JNK	NULL
activity	NULL
,	NULL
a	NULL
phenomenon	NULL
that	NULL
results	NULL
in	NULL
decreased	NULL
c-Jun	NULL
and	NULL
JunD	NULL
transactivation	NULL
activity	NULL
and	NULL
,	NULL
thus	NULL
,	NULL
diminished	NULL
autoinduction	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
genes	NULL
.	NULL

Discussion	NULL
The	NULL
genomic	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
,	NULL
are	NULL
mediated	NULL
by	NULL
a	NULL
ligand-inducible	NULL
transcription	NULL
factor	NULL
known	NULL
as	NULL
ER	NULL
.	NULL

After	NULL
the	NULL
discovery	NULL
of	NULL
a	NULL
second	NULL
ER	NULL
phenotype	NULL
(	NULL
ERB	NULL
)	NULL
,	NULL
the	NULL
first	NULL
identified	NULL
ER	NULL
is	NULL
now	NULL
known	NULL
as	NULL
ER	NULL
&	NULL
(	NULL
50	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
published	NULL
information	NULL
is	NULL
available	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
either	NULL
ERG	NULL
or	NULL
ERB	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocytic	NULL
lineage	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
murine	NULL
monocytic	NULL
cell	NULL
line	NULL
RAW	NULL
264.7	NULL
is	NULL
responsive	NULL
to	NULL
E	NULL
;	NULL
and	NULL
expresses	NULL
both	NULL
and	NULL
ERP	NULL
mRNAs	NULL
.	NULL

Although	NULL
ER	NULL
&	NULL
and	NULL
ERB	NULL
have	NULL
similar	NULL
DNA-binding	NULL
domains	NULL
,	NULL
their	NULL
A/B	NULL
domains	NULL
and	NULL
activation-function	NULL
region	NULL
1	NULL
(	NULL
AF-1	NULL
)	NULL
are	NULL
quite	NULL
different	NULL
,	NULL
suggesting	NULL
that	NULL
ER	NULL
&	NULL
and	NULL
ERfB	NULL
may	NULL
differentially	NULL
regulate	NULL
ER-responsive	NULL
genes	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
,	NULL
indeed	NULL
,	NULL
demonstrated	NULL
that	NULL
ER	NULL
&	NULL
and	NULL
ERB	NULL
respond	NULL
differently	NULL
to	NULL
ligand	NULL
,	NULL
leading	NULL
to	NULL
opposite	NULL
effects	NULL
on	NULL
AP-1-induced	NULL
gene	NULL
expression	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
although	NULL
the	NULL
ERa-mediated	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
lead	NULL
to	NULL
stimulation	NULL
of	NULL
AP-1-induced	NULL
gene	NULL
expression	NULL
,	NULL
E	NULL
;	NULL
acts	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
AP-1-induced	NULL
transcription	NULL
when	NULL
bound	NULL
to	NULL
ERR	NULL
(	NULL
52	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
these	NULL
data	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
TNF/CAT	NULL
reporter	NULL
construct	NULL
are	NULL
mediated	NULL
by	NULL
ERB	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
murine	NULL
TNF	NULL
promoter	NULL
revealed	NULL
that	NULL
silencing	NULL
of	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
full-length	NULL
TNF	NULL
promoter	NULL
abrogates	NULL
the	NULL
ability	NULL
of	NULL
IL-1	NULL
and	NULL
TNF	NULL
to	NULL
induce	NULL
TNF	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
findings	NULL
extend	NULL
previous	NULL
observations	NULL
demonstrating	NULL
that	NULL
the	NULL
AP-1	NULL
binding	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
PMA	NULL
induction	NULL
of	NULL
TNF	NULL
gene	NULL
expression	NULL
(	NULL
27	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
does	NULL
not	NULL
block	NULL
the	NULL
ability	NULL
of	NULL
LPS	NULL
to	NULL
induce	NULL
TNF	NULL
gene	NULL
expression	NULL
,	NULL
a	NULL
finding	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
LPS	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
murine	NULL
TNF	NULL
gene	NULL
primarily	NULL
by	NULL
activating	NULL
the	NULL
NF-KB	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Cytokine	NULL
stimulation	NULL
often	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
24	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
could	NULL
be	NULL
argued	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
should	NULL
not	NULL
repress	NULL
TNF	NULL
gene	NULL
expression	NULL
due	NULL
to	NULL
because	NULL
of	NULL
NF-KB	NULL
stimulation	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Because	NULL
mutation	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
decreased	NULL
TNF	NULL
gene	NULL
expression	NULL
by	NULL
approximately	NULL
4-fold	NULL
,	NULL
our	NULL
findings	NULL
suggest	NULL
the	NULL
possibility	NULL
that	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
cooperate	NULL
to	NULL
activate	NULL
the	NULL
murine	NULL
TNF	NULL
promoter	NULL
.	NULL

Regardless	NULL
of	NULL
whether	NULL
AP-1	NULL
interacts	NULL
with	NULL
NF-KB	NULL
,	NULL
the	NULL
data	NULL
demonstrate	NULL
the	NULL
critical	NULL
role	NULL
of	NULL
the	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
inflammatory	NULL
cytokines	NULL
induce	NULL
the	NULL
TNF	NULL
gene	NULL
.	NULL

A	NULL
surprising	NULL
finding	NULL
of	NULL
our	NULL
study	NULL
was	NULL
that	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
,	NULL
E	NULL
;	NULL
,	NULL
does	NULL
not	NULL
inhibit	NULL
NF-KB	NULL
binding	NULL
to	NULL
the	NULL
TNF	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
E	NULL
;	NULL
,	NULL
does	NULL
not	NULL
regulate	NULL
NF-xB-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
in	NULL
apparent	NULL
disagreement	NULL
with	NULL
reports	NULL
indicating	NULL
that	NULL
in	NULL
human	NULL
osteoblasts	NULL
,	NULL
E	NULL
;	NULL
represses	NULL
the	NULL
IL-6	NULL
promoter	NULL
by	NULL
blunting	NULL
NF-KB-induced	NULL
transcription	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
E	NULL
,	NULL
represses	NULL
NF-KB-induced	NULL
IL-6	NULL
production	NULL
in	NULL
human	NULL
osteoblasts	NULL
,	NULL
whereas	NULL
it	NULL
has	NULL
no	NULL
effects	NULL
on	NULL
NF-xB-induced	NULL
TNF	NULL
production	NULL
in	NULL
murine	NULL
monocytes	NULL
,	NULL
indicates	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
E	NULL
,	NULL
on	NULL
NF-KB-induced	NULL
gene	NULL
expression	NULL
are	NULL
promoter	NULL
and	NULL
cell	NULL
specific	NULL
.	NULL

510	NULL
The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|	NULL
_	NULL
Number4	NULL
In	NULL
accordance	NULL
with	NULL
the	NULL
key	NULL
role	NULL
of	NULL
AP-1	NULL
as	NULL
mediator	NULL
of	NULL
the	NULL
stimulatory	NULL
effects	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
on	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
,	NULL
we	NULL
found	NULL
that	NULL
E	NULL
,	NULL
downregulates	NULL
cytokine-induced	NULL
TNF	NULL
production	NULL
by	NULL
decreasing	NULL
the	NULL
binding	NULL
of	NULL
c-Jun/c-Fos	NULL
and	NULL
JunD/c-Fos	NULL
heterodimers	NULL
to	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
,	NULL
a	NULL
phenomenon	NULL
resulting	NULL
from	NULL
decreased	NULL
nuclear	NULL
levels	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
.	NULL

Attesting	NULL
to	NULL
specificity	NULL
,	NULL
our	NULL
data	NULL
also	NULL
demonstrate	NULL
that	NULL
E	NULL
,	NULL
does	NULL
not	NULL
regulate	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
Fos	NULL
proteins	NULL
.	NULL

Because	NULL
Fos	NULL
DNA	NULL
binding	NULL
is	NULL
proportional	NULL
to	NULL
the	NULL
nuclear	NULL
levels	NULL
of	NULL
Fos	NULL
proteins	NULL
,	NULL
our	NULL
findings	NULL
argue	NULL
against	NULL
the	NULL
possibility	NULL
that	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
E	NULL
,	NULL
on	NULL
Fos	NULL
DNA-binding	NULL
activity	NULL
contributes	NULL
to	NULL
the	NULL
downregulation	NULL
of	NULL
AP-1-induced	NULL
transcription	NULL
observed	NULL
in	NULL
E-treated	NULL
cells	NULL
.	NULL

Our	NULL
study	NULL
has	NULL
revealed	NULL
that	NULL
long-term	NULL
(	NULL
24-hour	NULL
)	NULL
Ez	NULL
treatment	NULL
decreases	NULL
the	NULL
levels	NULL
of	NULL
c-Jun	NULL
by	NULL
decreasing	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
gene	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
not	NULL
directly	NULL
assessed	NULL
the	NULL
effects	NULL
of	NULL
E	NULL
,	NULL
on	NULL
JunD	NULL
gene	NULL
expression	NULL
,	NULL
as	NULL
the	NULL
level	NULL
of	NULL
all	NULL
Jun	NULL
proteins	NULL
is	NULL
regulated	NULL
primarily	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
(	NULL
26	NULL
)	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
E	NULL
;	NULL
,	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
the	NULL
JunD	NULL
genes	NULL
.	NULL

The	NULL
transcription	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
is	NULL
regulated	NULL
by	NULL
2	NULL
TRE	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
genes	NULL
(	NULL
26	NULL
,	NULL
56	NULL
)	NULL
.	NULL

The	NULL
2	NULL
TRE	NULL
sites	NULL
of	NULL
each	NULL
gene	NULL
are	NULL
constitutively	NULL
occupied	NULL
by	NULL
c-Jun/ATF2	NULL
and	NULL
JunD/ATF2	NULL
heterodimers	NULL
(	NULL
26	NULL
,	NULL
56	NULL
)	NULL
,	NULL
which	NULL
generate	NULL
a	NULL
basal	NULL
rate	NULL
of	NULL
gene	NULL
autostimulation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
autoinduction	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
genes	NULL
by	NULL
Jun/ATF2	NULL
heterodimers	NULL
is	NULL
enhanced	NULL
by	NULL
phosphorylation	NULL
of	NULL
2	NULL
sites	NULL
within	NULL
the	NULL
NH-terminal	NULL
activation	NULL
domain	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
,	NULL
Ser	NULL
63	NULL
,	NULL
and	NULL
Ser	NULL
73	NULL
(	NULL
56	NULL
)	NULL
.	NULL

The	NULL
responsible	NULL
kinase	NULL
is	NULL
JNK	NULL
(	NULL
also	NULL
known	NULL
as	NULL
SAPK	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
(	NULL
MAPK	NULL
)	NULL
family	NULL
(	NULL
56	NULL
,	NULL
57	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
E	NULL
,	NULL
downregulates	NULL
JNK	NULL
activity	NULL
by	NULL
blocking	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
kinase	NULL
,	NULL
an	NULL
event	NULL
leading	NULL
to	NULL
decreased	NULL
NH	NULL
;	NULL
-terminal	NULL
phosphorylation	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
and	NULL
,	NULL
hence	NULL
,	NULL
diminished	NULL
autoinduction	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
promoters	NULL
.	NULL

Because	NULL
JNK	NULL
activation	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
stimulating	NULL
the	NULL
production	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
,	NULL
JNK	NULL
activation	NULL
is	NULL
also	NULL
critical	NULL
for	NULL
enhancing	NULL
the	NULL
expression	NULL
of	NULL
distal	NULL
genes	NULL
activated	NULL
by	NULL
AP-1	NULL
(	NULL
58	NULL
)	NULL
,	NULL
such	NULL
as	NULL
TNF	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Thus	NULL
our	NULL
data	NULL
demonstrate	NULL
that	NULL
a	NULL
key	NULL
mechanism	NULL
by	NULL
which	NULL
E	NULL
;	NULL
downregulates	NULL
AP-1-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
is	NULL
by	NULL
inhibiting	NULL
JNK	NULL
activity	NULL
.	NULL

Contrary	NULL
to	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
,	NULL
ER	NULL
modulates	NULL
AP-1-dependent	NULL
gene	NULL
expression	NULL
without	NULL
binding	NULL
to	NULL
either	NULL
DNA	NULL
or	NULL
AP-1	NULL
proteins	NULL
(	NULL
48	NULL
,	NULL
59	NULL
,	NULL
60	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
E	NULL
,	NULL
downregulates	NULL
JNK	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
AP-1-induced	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
,	NULL
JunD	NULL
,	NULL
and	NULL
TNF	NULL
gene	NULL
transcription	NULL
,	NULL
provide	NULL
a	NULL
novel	NULL
explanation	NULL
of	NULL
how	NULL
the	NULL
E	NULL
,	NULL
/ER	NULL
complex	NULL
represses	NULL
AP-1-induced	NULL
transcription	NULL
without	NULL
interacting	NULL
with	NULL
DNA	NULL
,	NULL
Jun	NULL
,	NULL
or	NULL
Fos	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
E	NULL
;	NULL
,	NULL
blunts	NULL
JNK	NULL
activation	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

E	NULL
,	NULL
may	NULL
downregulate	NULL
one	NULL
of	NULL
the	NULL
upstream	NULL
MAPKs	NULL
that	NULL
phosphorylate	NULL
and	NULL
activate	NULL
JNK	NULL
(	NULL
57	NULL
)	NULL
,	NULL
or	NULL
enhance	NULL
the	NULL
activity	NULL
of	NULL
phosphatases	NULL
that	NULL
deactivate	NULL
JNK	NULL
.	NULL

Among	NULL
these	NULL
are	NULL
the	NULL
ubiquitously	NULL
expressed	NULL
mouse	NULL
MAPK	NULL
phosphatases	NULL
1	NULL
and	NULL
2	NULL
(	NULL
61	NULL
)	NULL
.	NULL

Because	NULL
E	NULL
,	NULL
inhibits	NULL
JNK	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
production	NULL
of	NULL
Jun	NULL
and	NULL
TNF	NULL
,	NULL
only	NULL
when	NULL
cells	NULL
are	NULL
exposed	NULL
to	NULL
the	NULL
sex	NULL
steroid	NULL
for	NULL
at	NULL
least	NULL
12	NULL
hours	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
a	NULL
genomic	NULL
effect	NULL
of	NULL
E	NULL
;	NULL
inhibits	NULL
the	NULL
production	NULL
of	NULL
a	NULL
protein	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
JNK	NULL
.	NULL

According	NULL
to	NULL
this	NULL
model	NULL
,	NULL
the	NULL
time	NULL
course	NULL
of	NULL
JNK	NULL
inhibition	NULL
would	NULL
parallel	NULL
the	NULL
decay	NULL
of	NULL
the	NULL
regulated	NULL
protein	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
E	NULL
,	NULL
downregulates	NULL
JNK	NULL
activity	NULL
does	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
additional	NULL
mechanisms	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
E	NULL
;	NULL
on	NULL
the	NULL
production	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
.	NULL

For	NULL
example	NULL
,	NULL
E	NULL
;	NULL
could	NULL
increase	NULL
the	NULL
COOH-terminal	NULL
phosphorylation	NULL
of	NULL
these	NULL
proteins	NULL
,	NULL
thus	NULL
impairing	NULL
their	NULL
binding	NULL
to	NULL
DNA	NULL
(	NULL
62	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
E	NULL
,	NULL
could	NULL
repress	NULL
p38	NULL
,	NULL
the	NULL
kinase	NULL
that	NULL
,	NULL
by	NULL
phospho-rylating	NULL
ATF-2	NULL
,	NULL
contributes	NULL
to	NULL
the	NULL
autoinduction	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
promoters	NULL
(	NULL
63	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
compounds	NULL
that	NULL
block	NULL
p38	NULL
do	NULL
not	NULL
diminish	NULL
TNF	NULL
mRNA	NULL
accumulation	NULL
,	NULL
but	NULL
instead	NULL
diminish	NULL
TNF	NULL
protein	NULL
production	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Given	NULL
that	NULL
we	NULL
have	NULL
found	NULL
that	NULL
E	NULL
;	NULL
,	NULL
decreases	NULL
TNF	NULL
mRNA	NULL
levels	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
E	NULL
;	NULL
regulates	NULL
the	NULL
activation	NULL
of	NULL
p38	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
found	NULL
that	NULL
in	NULL
the	NULL
murine	NULL
myeloid	NULL
cell	NULL
line	NULL
RAW	NULL
264.7	NULL
,	NULL
E	NULL
,	NULL
downregulates	NULL
TNF	NULL
production	NULL
by	NULL
decreasing	NULL
the	NULL
binding	NULL
of	NULL
c-Jun/c-Fos	NULL
and	NULL
JunD/c-Fos	NULL
a	NULL
a	NULL
ng	NULL
'	NULL
ﬂ	NULL
MJ	NULL
-	NULL
#	NULL
-	NULL
4	NULL
=	NULL
+	NULL
GST	NULL
eJun	NULL
{	NULL
1-79	NULL
)	NULL
&	NULL
&	NULL
t	NULL
i	NULL
..	NULL
42	NULL
kDa	NULL
(	NULL
1	NULL
5	NULL
15	NULL
Time	NULL
(	NULL
minule	NULL
«	NULL
}	NULL
b	NULL
E	NULL
Egghj	NULL
MJ	NULL
L0	NULL
..	NULL
to	NULL
.	NULL

JNKL	NULL
--	NULL
cag	NULL
meee	NULL
us	NULL
n	NULL
ccs	NULL
54	NULL
kDa	NULL
JNK	NULL
1	NULL
=	NULL
1	NULL
Tt	NULL
-~	NULL
46	NULL
kDa	NULL
Q	NULL
5	NULL
15	NULL
Tima	NULL
{	NULL
minutas	NULL
)	NULL
C	NULL
54	NULL
KDB	NULL
mme	NULL
«	NULL
cmm	NULL
:	NULL
46	NULL
kDa	NULL
.	NULL

seee	NULL
a	NULL
«	NULL
-Unstmulated	NULL
calls	NULL
IL-1	NULL
+	NULL
THF	NULL
stimulated	NULL
cels	NULL
Figure	NULL
9	NULL
(	NULL
a	NULL
)	NULL
E	NULL
,	NULL
decreases	NULL
JNK	NULL
activity	NULL
in	NULL
RAW	NULL
264.7	NULL
cells	NULL
.	NULL

RAW	NULL
264.7	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
either	NULL
E	NULL
;	NULL
or	NULL
vehicle	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
IL-1	NULL
and	NULL
TNF	NULL
for	NULL
0-15	NULL
minutes	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
then	NULL
immunoprecipitated	NULL
by	NULL
anti-JNK	NULL
antibody	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
immunoprecipitation	NULL
material	NULL
were	NULL
recovered	NULL
and	NULL
incubated	NULL
with	NULL
recombinant	NULL
GST-c-Jun	NULL
and	NULL
[	NULL
y-32PJATP	NULL
.	NULL

Phosphorylated	NULL
material	NULL
was	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
viewed	NULL
by	NULL
autoradiography	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
experiment	NULL
.	NULL

(	NULL
b	NULL
)	NULL
E	NULL
;	NULL
has	NULL
no	NULL
effects	NULL
on	NULL
total	NULL
JNK	NULL
levels	NULL
.	NULL

Western	NULL
blot	NULL
studies	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
in	NULL
the	NULL
text	NULL
using	NULL
an	NULL
antibody	NULL
that	NULL
recognizes	NULL
the	NULL
dephosphorylated	NULL
and	NULL
the	NULL
phosphorylated	NULL
species	NULL
of	NULL
both	NULL
JNK1	NULL
and	NULL
JNK2	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

(	NULL
c	NULL
)	NULL
E	NULL
;	NULL
decreases	NULL
the	NULL
level	NULL
of	NULL
phosphorylated	NULL
(	NULL
active	NULL
JNK	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
conducted	NULL
using	NULL
cell	NULL
lysates	NULL
from	NULL
control-	NULL
and	NULL
E	NULL
;	NULL
-treated	NULL
RAW	NULL
264.7	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-1B	NULL
and	NULL
TNF	NULL
for	NULL
5	NULL
minutes	NULL
,	NULL
and	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
phospho	NULL
JNK	NULL
.	NULL

Representative	NULL
data	NULL
from	NULL
1	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|_	NULL
Number	NULL
4	NULL
511	NULL
512	NULL
heterodimers	NULL
to	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
in	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

Decreased	NULL
binding	NULL
of	NULL
these	NULL
complexes	NULL
to	NULL
the	NULL
TNF	NULL
promoter	NULL
results	NULL
from	NULL
diminished	NULL
levels	NULL
of	NULL
cJun	NULL
and	NULL
JunD	NULL
,	NULL
whose	NULL
production	NULL
is	NULL
reduced	NULL
by	NULL
an	NULL
inhibitory	NULL
effect	NULL
of	NULL
E	NULL
;	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
JNK	NULL
,	NULL
an	NULL
enzyme	NULL
that	NULL
phosphorylates	NULL
c-Jun	NULL
and	NULL
JunD	NULL
in	NULL
their	NULL
NH	NULL
>	NULL
-ter-mini	NULL
.	NULL

NH	NULL
;	NULL
terminally	NULL
phosphorylated	NULL
c-Jun	NULL
and	NULL
JunD	NULL
interact	NULL
with	NULL
AP-1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
promoters	NULL
and	NULL
autostimulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
c-Jun	NULL
and	NULL
JunD	NULL
genes	NULL
(	NULL
65	NULL
,	NULL
66	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
E	NULL
,	NULL
-mediated	NULL
inhibition	NULL
of	NULL
JNK	NULL
activity	NULL
downregulates	NULL
the	NULL
autostimulated	NULL
expression	NULL
of	NULL
c-Jun	NULL
and	NULL
JunD	NULL
genes	NULL
,	NULL
resulting	NULL
in	NULL
decreased	NULL
AP-1-induced	NULL
TNF	NULL
gene	NULL
expression	NULL
.	NULL

Inhibition	NULL
of	NULL
TNF	NULL
production	NULL
is	NULL
one	NULL
of	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
Ez	NULL
prevents	NULL
osteoclast	NULL
formation	NULL
and	NULL
bone	NULL
loss	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
results	NULL
of	NULL
this	NULL
study	NULL
are	NULL
relevant	NULL
for	NULL
the	NULL
pathogenesis	NULL
and	NULL
the	NULL
treatment	NULL
of	NULL
postmenopausal	NULL
osteoporosis	NULL
,	NULL
as	NULL
identification	NULL
of	NULL
the	NULL
molecular	NULL
targets	NULL
of	NULL
E	NULL
;	NULL
in	NULL
monocytes	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
development	NULL
of	NULL
new	NULL
anti-osteoclastogenic	NULL
therapeutic	NULL
agents	NULL
.	NULL

Acknowledgments	NULL
This	NULL
study	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Lilly	NULL
Center	NULL
for	NULL
Women	NULL
's	NULL
Health	NULL
,	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
AR-41412	NULL
and	NULL
AR-45829	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Barnes-Jewish	NULL
Hospital	NULL
Research	NULL
Foundation	NULL
.	NULL

1	NULL
.	NULL

Manolagas	NULL
,	NULL
S.C.	NULL
,	NULL
and	NULL
Jilka	NULL
,	NULL
RL	NULL
.	NULL

1995	NULL
.	NULL

Bone	NULL
marrow	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
bone	NULL
remodeling	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

332:305-311	NULL
.	NULL

2	NULL
.	NULL

Gowen	NULL
,	NULL
M.	NULL
,	NULL
Wood	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
Ihrie	NULL
,	NULL
EJ	NULL
.	NULL

,	NULL
McGuire	NULL
,	NULL
M.K.B	NULL
.	NULL

,	NULL
and	NULL
Russell	NULL
,	NULL
R.G.G	NULL
.	NULL

1983	NULL
.	NULL

An	NULL
interleukin-1	NULL
-like	NULL
factor	NULL
stimulates	NULL
bone	NULL
resorption	NULL
in	NULL
vitro	NULL
.	NULL

Nature	NULL
.	NULL

306:378-380	NULL
.	NULL

3	NULL
.	NULL

Horowitz	NULL
,	NULL
M.	NULL
1993	NULL
.	NULL

Cytokines	NULL
and	NULL
estrogen	NULL
in	NULL
bone	NULL
:	NULL
anti-osteoporotic	NULL
effects	NULL
.	NULL

Science	NULL
.	NULL

260:626-627	NULL
.	NULL

4	NULL
.	NULL

Dinarello	NULL
,	NULL
C.A	NULL
.	NULL

1991	NULL
.	NULL

Interleukin-1	NULL
and	NULL
interleukin-1	NULL
antagonism	NULL
.	NULL

Blood	NULL
.	NULL

77:1627-1652	NULL
.	NULL

5	NULL
.	NULL

Dexter	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Allen	NULL
,	NULL
T.D	NULL
.	NULL

,	NULL
and	NULL
Lajyha	NULL
,	NULL
LG	NULL
.	NULL

1977	NULL
.	NULL

Conditions	NULL
controlling	NULL
the	NULL
proliferation	NULL
of	NULL
hematopoietic	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

91:335-344	NULL
.	NULL

6	NULL
.	NULL

Dexter	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
.	NULL

Stromal	NULL
cells	NULL
in	NULL
haemopoiesis	NULL
.	NULL

In	NULL
Molecular	NULL
control	NULL
of	NULL
haemopoiesis	NULL
.	NULL

G.	NULL
Bock	NULL
and	NULL
J.	NULL
Marsh	NULL
,	NULL
editors	NULL
.	NULL

John	NULL
Wiley	NULL
&	NULL
Sons	NULL
Ltd.	NULL
West	NULL
Sussex	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

86-95	NULL
.	NULL

7	NULL
.	NULL

Lacey	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Osteoprotegerin	NULL
ligand	NULL
is	NULL
a	NULL
cytokine	NULL
that	NULL
regulates	NULL
osteoclast	NULL
differentiation	NULL
and	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

93:165-176	NULL
.	NULL

8	NULL
.	NULL

Quinn	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Elliott	NULL
,	NULL
J.	NULL
,	NULL
Gillespie	NULL
,	NULL
M.T	NULL
.	NULL

,	NULL
and	NULL
Martin	NULL
,	NULL
TJ	NULL
.	NULL

1998	NULL
.	NULL

A	NULL
combination	NULL
of	NULL
osteoclast	NULL
differentiation	NULL
factor	NULL
and	NULL
macrophage-colony	NULL
stimulating	NULL
factor	NULL
is	NULL
sufficient	NULL
for	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
osteoclast	NULL
formation	NULL
in	NULL
vitro	NULL
.	NULL

Endocrinology	NULL
.	NULL

139:4424-4427	NULL
.	NULL

9	NULL
.	NULL

Suda	NULL
,	NULL
T.	NULL
,	NULL
Takahashi	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Martin	NULL
,	NULL
T.J.	NULL
1992	NULL
.	NULL

Modulation	NULL
of	NULL
osteoclast	NULL
differentiation	NULL
.	NULL

Endocr	NULL
.	NULL

Rev	NULL
.	NULL

13:66-80	NULL
.	NULL

10	NULL
.	NULL

Yoshida	NULL
,	NULL
H.S	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
murine	NULL
mutation	NULL
osteopetrosis	NULL
is	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
gene	NULL
.	NULL

Nature	NULL
.	NULL

345:442-444	NULL
.	NULL

11	NULL
.	NULL

Kimble	NULL
,	NULL
R.	NULL
,	NULL
Bain	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Pacifici	NULL
,	NULL
R.	NULL
1997	NULL
.	NULL

The	NULL
functional	NULL
block	NULL
of	NULL
TNF	NULL
but	NULL
not	NULL
of	NULL
IL-6	NULL
prevents	NULL
bone	NULL
loss	NULL
in	NULL
ovariectomized	NULL
mice	NULL
.	NULL

J	NULL
.	NULL

Bone	NULL
Miner	NULL
.	NULL

Res	NULL
.	NULL

12:935-941	NULL
.	NULL

12	NULL
.	NULL

Ammann	NULL
,	NULL
P.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Transgenic	NULL
mice	NULL
expressing	NULL
soluble	NULL
tumor	NULL
necrosis	NULL
factor-receptor	NULL
are	NULL
protected	NULL
against	NULL
bone	NULL
loss	NULL
caused	NULL
by	NULL
estrogen	NULL
deficiency	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

99:1699-1703	NULL
.	NULL

13	NULL
.	NULL

Pacifici	NULL
,	NULL
R.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
.	NULL

Effect	NULL
of	NULL
surgical	NULL
menopause	NULL
and	NULL
estrogen	NULL
replacement	NULL
on	NULL
cytokine	NULL
release	NULL
from	NULL
human	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:5134-5138	NULL
.	NULL

14	NULL
.	NULL

Pacifici	NULL
,	NULL
R.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
.	NULL

Ovarian	NULL
steroid	NULL
treatment	NULL
blocks	NULL
a	NULL
postmenopausal	NULL
increase	NULL
in	NULL
blood	NULL
monocyte	NULL
interleukin	NULL
1	NULL
release	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:2398-2402	NULL
.	NULL

15	NULL
.	NULL

Ralston	NULL
,	NULL
S.H	NULL
.	NULL

1994	NULL
.	NULL

Analysis	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
bone	NULL
biopsies	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
:	NULL
evidence	NULL
for	NULL
enhanced	NULL
cytokine	NULL
expression	NULL
in	NULL
postmenopausal	NULL
osteoporosis	NULL
.	NULL

J	NULL
.	NULL

Bone	NULL
Miner	NULL
.	NULL

Res	NULL
.	NULL

9:883-890	NULL
.	NULL

16	NULL
.	NULL

Kimble	NULL
,	NULL
R.B	NULL
.	NULL

,	NULL
Srivastava	NULL
,	NULL
S.	NULL
,	NULL
Ross	NULL
,	NULL
F.P	NULL
.	NULL

,	NULL
Matayoshi	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Pacifici	NULL
,	NULL
R.	NULL
1996	NULL
.	NULL

Estrogen	NULL
deficiency	NULL
increases	NULL
the	NULL
ability	NULL
of	NULL
stromal	NULL
cells	NULL
to	NULL
support	NULL
osteoclastogenesis	NULL
via	NULL
an	NULL
IL-1	NULL
and	NULL
TNF	NULL
mediated	NULL
stimulation	NULL
of	NULL
M-CSF	NULL
production	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:28890-28897	NULL
.	NULL

17	NULL
.	NULL

Ralston	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
Russell	NULL
,	NULL
R.G.G	NULL
.	NULL

,	NULL
and	NULL
Gowen	NULL
,	NULL
M.	NULL
1990	NULL
.	NULL

Estrogen	NULL
inhibits	NULL
release	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
in	NULL
postmenopausal	NULL
women	NULL
.	NULL

J	NULL
.	NULL

Bone	NULL
Miner	NULL
.	NULL

Res	NULL
.	NULL

5:983-988	NULL
.	NULL

18	NULL
.	NULL

Shanker	NULL
,	NULL
G.	NULL
,	NULL
Sorci-Thomas	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Adams	NULL
,	NULL
M.R	NULL
.	NULL

1994	NULL
.	NULL

Estrogen	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
mRNA	NULL
in	NULL
phorbol	NULL
ester-stimulated	NULL
human	NULL
monocytic	NULL
THP-1	NULL
cells	NULL
.	NULL

Lymphokine	NULL
Cytokine	NULL
Res	NULL
.	NULL

13:377-382	NULL
.	NULL

19	NULL
.	NULL

Sung	NULL
,	NULL
S.S.	NULL
,	NULL
Bjorndahl	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
C.Y	NULL
.	NULL

,	NULL
Kao	NULL
,	NULL
H.T	NULL
.	NULL

,	NULL
and	NULL
Fu	NULL
,	NULL
S.M	NULL
.	NULL

1988	NULL
.	NULL

Production	NULL
of	NULL
turnor	NULL
necrosis	NULL
factor/cachectin	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
stimulated	NULL
by	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
and	NULL
anti-CD3	NULL
antibody	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167:937-953	NULL
.	NULL

20	NULL
.	NULL

Yao	NULL
,	NULL
J.	NULL
,	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Edgington	NULL
,	NULL
T.S	NULL
.	NULL

,	NULL
and	NULL
Fan	NULL
,	NULL
S.T	NULL
.	NULL

1997	NULL
.	NULL

Lipopolysac-charide	NULL
induction	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
promoter	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

Regulation	NULL
by	NULL
Egr-1	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
NF-kappaB	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:17795-17801	NULL
.	NULL

21.Philip	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Epstein	NULL
,	NULL
LB	NULL
.	NULL

1986	NULL
.	NULL

Tumour	NULL
necrosis	NULL
factor	NULL
as	NULL
immunomodulator	NULL
and	NULL
mediator	NULL
of	NULL
monocyte	NULL
cytotoxicity	NULL
induced	NULL
by	NULL
itself	NULL
,	NULL
Y-interferon	NULL
and	NULL
interleukin-1	NULL
.	NULL

Nature	NULL
.	NULL

323:86-89	NULL
.	NULL

22	NULL
.	NULL

Chaplin	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
and	NULL
Hoggist	NULL
,	NULL
K.	NULL
1992	NULL
.	NULL

Interactions	NULL
between	NULL
TNF	NULL
and	NULL
interleukin-1	NULL
.	NULL

In	NULL
Temor	NULL
necrosis	NULL
factors	NULL
:	NULL
the	NULL
molecules	NULL
and	NULL
their	NULL
emerging	NULL
role	NULL
in	NULL
medicine	NULL
.	NULL

B.	NULL
Beutler	NULL
,	NULL
editor	NULL
.	NULL

Raven	NULL
Press	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

197-220	NULL
.	NULL

23	NULL
.	NULL

Dinarello	NULL
,	NULL
C.A	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
pathophysiology	NULL
of	NULL
the	NULL
pro-inflammatory	NULL
cytokines	NULL
.	NULL

Biotherapy	NULL
.	NULL

2:189-191	NULL
.	NULL

24	NULL
.	NULL

Brenner	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
O'Hara	NULL
,	NULL
M.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Chojkier	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
1989	NULL
.	NULL

Prolonged	NULL
activation	NULL
of	NULL
jun	NULL
and	NULL
collagenase	NULL
genes	NULL
by	NULL
tumour	NULL
necrosis	NULL
factor-alpha	NULL
.	NULL

Nature	NULL
.	NULL

337:661-663	NULL
.	NULL

25	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
1991	NULL
.	NULL

The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
the	NULL
AP-1	NULL
complex	NULL
in	NULL
cell-proliferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1072:129-157	NULL
.	NULL

26	NULL
.	NULL

Foletta	NULL
,	NULL
V.C	NULL
.	NULL

,	NULL
Segal	NULL
,	NULL
D.H.	NULL
,	NULL
and	NULL
Cohen	NULL
,	NULL
D.R	NULL
.	NULL

1998	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
:	NULL
all	NULL
roads	NULL
lead	NULL
to	NULL
AP-1	NULL
.	NULL

J.	NULL
Lewkoc	NULL
.	NULL

Biol	NULL
.	NULL

63:139-152	NULL
.	NULL

27	NULL
.	NULL

Rhoades	NULL
,	NULL
KL	NULL
.	NULL

,	NULL
Golub	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
and	NULL
Economou	NULL
,	NULL
J.S	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
promoter	NULL
region	NULL
in	NULL
macrophage	NULL
,	NULL
T	NULL
cell	NULL
,	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:22102-22107	NULL
.	NULL

28	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
T.	NULL
1991	NULL
.	NULL

A	NULL
CAT	NULL
reporter	NULL
construct	NULL
allows	NULL
ultra-sensitive	NULL
estimation	NULL
of	NULL
TNF	NULL
synthesis	NULL
,	NULL
and	NULL
suggests	NULL
that	NULL
the	NULL
TNF-gene	NULL
has	NULL
been	NULL
silenced	NULL
in	NULL
non-macrophage	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:1336-1344	NULL
.	NULL

29	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

1990	NULL
.	NULL

Endotoxin-responsive	NULL
sequences	NULL
control	NULL
cachectin/tumor	NULL
necrosis	NULL
factor	NULL
biosynthesis	NULL
at	NULL
the	NULL
translation-al	NULL
level	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:465-475	NULL
.	NULL

30	NULL
.	NULL

Hemsley	NULL
,	NULL
A.	NULL
,	NULL
Arnheim	NULL
,	NULL
N.	NULL
,	NULL
Toney	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Cortopassi	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Galas	NULL
,	NULL
DJ	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
simple	NULL
method	NULL
for	NULL
site-directed	NULL
mutagenesis	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6545-6551	NULL
.	NULL

31	NULL
.	NULL

Rifas	NULL
,	NULL
L.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Production	NULL
of	NULL
interleukin-6	NULL
in	NULL
human	NULL
osteoblasts	NULL
and	NULL
human	NULL
bone	NULL
marrow	NULL
stromal	NULL
cells	NULL
:	NULL
evidence	NULL
that	NULL
induction	NULL
by	NULL
interleukin-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
@	NULL
is	NULL
not	NULL
regulated	NULL
by	NULL
ovarian	NULL
steroids	NULL
.	NULL

Endocrinology	NULL
.	NULL

136:4056-4067	NULL
.	NULL

32	NULL
.	NULL

Tora	NULL
,	NULL
L.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
cloned	NULL
human	NULL
oestrogen	NULL
receptor	NULL
contains	NULL
a	NULL
mutation	NULL
which	NULL
alters	NULL
its	NULL
hormone	NULL
binding	NULL
properties	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:1981-1986	NULL
.	NULL

33	NULL
.	NULL

Meyers	NULL
,	NULL
C.Y	NULL
.	NULL

,	NULL
Lutfi	NULL
,	NULL
H.G	NULL
.	NULL

,	NULL
and	NULL
Adler	NULL
,	NULL
S.	NULL
1997	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
estrogen-responsive	NULL
genes	NULL
by	NULL
non-steroidal	NULL
estrogens	NULL
:	NULL
doisynolic	NULL
and	NULL
allenolic	NULL
acids	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

62:47	NULL
7-489	NULL
.	NULL

34	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
.	NULL

Cold	NULL
Spring	NULL
Har-bor	NULL
,	NULL
NY	NULL
.	NULL

16.60	NULL
.	NULL

35	NULL
.	NULL

Godambe	NULL
,	NULL
S.A.	NULL
,	NULL
Chaplin	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
Takora	NULL
,	NULL
T.	NULL
,	NULL
Read	NULL
,	NULL
LM	NULL
.	NULL

,	NULL
and	NULL
Bellone	NULL
,	NULL
C.J	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
cis-acting	NULL
element	NULL
for	NULL
lipopolysaccharide-induced	NULL
transcription	NULL
of	NULL
the	NULL
murine	NULL
interleukin-1	NULL
B	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:112-119	NULL
.	NULL

36	NULL
.	NULL

Hall	NULL
,	NULL
C.V.	NULL
,	NULL
Jacob	NULL
,	NULL
P.E	NULL
.	NULL

,	NULL
Ringold	NULL
,	NULL
G.M	NULL
.	NULL

,	NULL
and	NULL
Lee	NULL
,	NULL
F.	NULL
1983	NULL
.	NULL

Expression	NULL
and	NULL
regulation	NULL
of	NULL
Escherichia	NULL
coli	NULL
Lac	NULL
Z	NULL
fusion	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Appl	NULL
.	NULL

Genet	NULL
.	NULL

2:101-109	NULL
.	NULL

37	NULL
.	NULL

Kitazawa	NULL
,	NULL
R.	NULL
,	NULL
Kimble	NULL
,	NULL
R.B	NULL
.	NULL

,	NULL
Vannice	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Kung	NULL
,	NULL
VT.	NULL
,	NULL
and	NULL
Pacifici	NULL
,	NULL
R.	NULL
1994	NULL
.	NULL

Interleukin-1	NULL
receptor	NULL
antagonist	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
binding	NULL
protein	NULL
decrease	NULL
osteoclast	NULL
formation	NULL
and	NULL
bone	NULL
resorption	NULL
in	NULL
ovariectomized	NULL
mice	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94:2397-2406	NULL
.	NULL

38	NULL
.	NULL

Lu	NULL
,	NULL
B.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Estrogen	NULL
receptor-beta	NULL
mRNA	NULL
variants	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
tissues	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Endocrinol	NULL
.	NULL

138:199-203	NULL
.	NULL

39	NULL
.	NULL

Chaplin	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
.	NULL

Molecular	NULL
map	NULL
of	NULL
the	NULL
murine	NULL
S	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

80:6947-6951	NULL
.	NULL

40	NULL
.	NULL

Abu-Amer	NULL
,	NULL
Y.	NULL
,	NULL
Ross	NULL
,	NULL
FP	NULL
.	NULL

,	NULL
Edwards	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Teitelbaum	NULL
,	NULL
S.L	NULL
.	NULL

1997	NULL
.	NULL

Lipopolysaccharide-stimulated	NULL
osteoclastogenesis	NULL
is	NULL
mediated	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
via	NULL
its	NULL
P55	NULL
receptor	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:1557-1565	NULL
.	NULL

41	NULL
.	NULL

Srivastava	NULL
,	NULL
S.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Estrogen	NULL
blocks	NULL
M-CSF	NULL
gene	NULL
expression	NULL
and	NULL
osteoclast	NULL
formation	NULL
by	NULL
regulating	NULL
CKI-induced	NULL
phosphorylation	NULL
of	NULL
Egr-1	NULL
and	NULL
its	NULL
interaction	NULL
with	NULL
§p-1	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

102:1850-1859	NULL
.	NULL

42	NULL
.	NULL

Jain	NULL
,	NULL
N.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Casein	NULL
kinase	NULL
II	NULL
associates	NULL
with	NULL
Egr-1	NULL
and	NULL
acts	NULL
as	NULL
a	NULL
negative	NULL
modulator	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
and	NULL
transcription	NULL
activities	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:13530-13536	NULL
.	NULL

43	NULL
.	NULL

Towbin	NULL
,	NULL
H.	NULL
,	NULL
Stachelin	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Gordon	NULL
,	NULL
J	NULL
.	NULL

1979	NULL
.	NULL

Electrophoretic	NULL
transfer	NULL
of	NULL
proteins	NULL
from	NULL
polyacrylamide	NULL
gels	NULL
to	NULL
nitrocellulose	NULL
sheets	NULL
:	NULL
procedure	NULL
and	NULL
some	NULL
applications	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

76:4350-4354	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume	NULL
104	NULL
|	NULL
_	NULL
Number4	NULL
44	NULL
.	NULL

Hibi	NULL
,	NULL
M.	NULL
,	NULL
Lin	NULL
,	NULL
A.	NULL
,	NULL
Smeal	NULL
,	NULL
T.	NULL
,	NULL
Minden	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
1993	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
oncoprotein-	NULL
and	NULL
UV-responsive	NULL
protein	NULL
kinase	NULL
that	NULL
binds	NULL
and	NULL
potentiates	NULL
the	NULL
c-Jun	NULL
activation	NULL
domain	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2135-2148	NULL
.	NULL

45	NULL
.	NULL

Chan	NULL
,	NULL
E.D	NULL
.	NULL

,	NULL
Winston	NULL
,	NULL
B.W	NULL
.	NULL

,	NULL
Jarpe	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Wynes	NULL
,	NULL
M.W	NULL
.	NULL

,	NULL
and	NULL
Riches	NULL
,	NULL
D.W.	NULL
1997	NULL
.	NULL

Preferential	NULL
activation	NULL
of	NULL
the	NULL
p46	NULL
isoform	NULL
of	NULL
JNK/SAPK	NULL
in	NULL
mouse	NULL
macrophages	NULL
by	NULL
TNF	NULL
alpha	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

94:13169-13174	NULL
.	NULL

46	NULL
.	NULL

Reinhard	NULL
,	NULL
C.	NULL
,	NULL
Shamoon	NULL
,	NULL
B.	NULL
,	NULL
Shyamala	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Williams	NULL
,	NULL
LT.	NULL
1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha-induced	NULL
activation	NULL
of	NULL
c-jun	NULL
N-terminal	NULL
kinase	NULL
is	NULL
mediated	NULL
by	NULL
TRAF2	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:1080-1092	NULL
.	NULL

47	NULL
.	NULL

Beutler	NULL
,	NULL
B	NULL
.	NULL

1992	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factors	NULL
:	NULL
the	NULL
molecules	NULL
and	NULL
their	NULL
emerging	NULL
role	NULL
in	NULL
medicine	NULL
.	NULL

Raven	NULL
Press	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

485-577	NULL
.	NULL

48	NULL
.	NULL

Webb	NULL
,	NULL
P.	NULL
,	NULL
Lopez	NULL
,	NULL
G.N	NULL
.	NULL

,	NULL
Uht	NULL
,	NULL
RM	NULL
.	NULL

,	NULL
and	NULL
Kusher	NULL
,	NULL
PJ	NULL
.	NULL

1995	NULL
.	NULL

Tamoxifen	NULL
activation	NULL
of	NULL
the	NULL
estrogen	NULL
receptor/AP-1	NULL
pathway	NULL
:	NULL
potential	NULL
origin	NULL
for	NULL
the	NULL
cell-specific	NULL
estrogen-like	NULL
effects	NULL
of	NULL
antiestrogens	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

9:443-456	NULL
.	NULL

49	NULL
.	NULL

Wei	NULL
,	NULL
P.	NULL
,	NULL
Inamdar	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Vedeckis	NULL
,	NULL
W.V	NULL
.	NULL

1998	NULL
.	NULL

Transrepression	NULL
of	NULL
c-jun	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
requires	NULL
both	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
c-jun	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

12:1322-1333	NULL
.	NULL

50	NULL
.	NULL

Kuiper	NULL
,	NULL
G.G	NULL
.	NULL

,	NULL
Enmark	NULL
,	NULL
E.	NULL
,	NULL
Pelto-Huikko	NULL
,	NULL
M.	NULL
,	NULL
Nilsson	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Gustafsson	NULL
,	NULL
J.A	NULL
.	NULL

1996	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
novel	NULL
receptor	NULL
expressed	NULL
in	NULL
rat	NULL
prostate	NULL
and	NULL
ovary	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

93:5925-5930	NULL
.	NULL

51	NULL
.	NULL

Couse	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Lindzey	NULL
,	NULL
J.	NULL
,	NULL
Grandien	NULL
,	NULL
K.	NULL
,	NULL
Gustafsson	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
and	NULL
Korach	NULL
,	NULL
K.S	NULL
.	NULL

1997	NULL
.	NULL

Tissue	NULL
distribution	NULL
and	NULL
quantitative	NULL
analysis	NULL
of	NULL
estrogen	NULL
receptor-alpha	NULL
(	NULL
ERalpha	NULL
)	NULL
and	NULL
estrogen	NULL
receptor-beta	NULL
(	NULL
ERbeta	NULL
)	NULL
messenger	NULL
ribonu-cleic	NULL
acid	NULL
in	NULL
the	NULL
wild-type	NULL
and	NULL
ERalpha-knockout	NULL
mouse	NULL
.	NULL

Endocrinology	NULL
.	NULL

138:4613-4621	NULL
.	NULL

52	NULL
.	NULL

Paech	NULL
,	NULL
K.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
ligand	NULL
activation	NULL
of	NULL
estrogen	NULL
receptors	NULL
ERalpha	NULL
and	NULL
ERbeta	NULL
at	NULL
APL	NULL
sites	NULL
.	NULL

Science	NULL
.	NULL

277:1508-1510	NULL
.	NULL

53	NULL
.	NULL

Shakhov	NULL
,	NULL
A.N	NULL
.	NULL

,	NULL
Collart	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.A.	NULL
,	NULL
and	NULL
Jonge-neel	NULL
,	NULL
C.V.	NULL
1990.	NULL
kB	NULL
enhancers	NULL
are	NULL
involved	NULL
in	NULL
liposaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
TNF	NULL
@	NULL
gene	NULL
in	NULL
primary	NULL
macrophages	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:35-47	NULL
.	NULL

54	NULL
.	NULL

Muegge	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Durum	NULL
,	NULL
S.	NULL
1990	NULL
.	NULL

Cytokines	NULL
and	NULL
transcription	NULL
factors	NULL
[	NULL
review	NULL
]	NULL
.	NULL

Cytokine	NULL
.	NULL

2:1-8	NULL
.	NULL

55	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
M.X	NULL
.	NULL

1995	NULL
.	NULL

Repression	NULL
of	NULL
the	NULL
interleukin-6	NULL
promot-	NULL
er	NULL
by	NULL
estrogen	NULL
receptor	NULL
is	NULL
mediated	NULL
by	NULL
NF-kappa-B	NULL
and	NULL
C/EBP-BETA	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:4971-4979	NULL
.	NULL

56	NULL
.	NULL

Minden	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
1997	NULL
.	NULL

Regulation	NULL
and	NULL
function	NULL
of	NULL
the	NULL
JNK	NULL
subgroup	NULL
of	NULL
MAP	NULL
kinases	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1333	NULL
:	NULL
F85-F104	NULL
.	NULL

57	NULL
.	NULL

Ip	NULL
,	NULL
Y.T	NULL
.	NULL

,	NULL
and	NULL
Davis	NULL
,	NULL
R.J.	NULL
1998	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
:	NULL
from	NULL
inflammation	NULL
to	NULL
development	NULL
.	NULL

Carr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

10:205-219	NULL
.	NULL

58	NULL
.	NULL

Westwick	NULL
,	NULL
J.K.	NULL
,	NULL
Weitzel	NULL
,	NULL
C.	NULL
,	NULL
Minden	NULL
,	NULL
A.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Brenner	NULL
,	NULL
D.A	NULL
.	NULL

1994	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
stimulates	NULL
AP-1	NULL
activity	NULL
through	NULL
prolonged	NULL
activation	NULL
of	NULL
the	NULL
c-Jun	NULL
kinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:26396-26401	NULL
.	NULL

59	NULL
.	NULL

Schmitt	NULL
,	NULL
M.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Positive	NULL
and	NULL
negative	NULL
effects	NULL
of	NULL
nuclear	NULL
receptors	NULL
on	NULL
transcription	NULL
activation	NULL
by	NULL
AP-1	NULL
of	NULL
the	NULL
human	NULL
choline	NULL
acetyl-transferase	NULL
proximal	NULL
promoter	NULL
.	NULL

J.	NULL
Nesrosci	NULL
.	NULL

Res	NULL
.	NULL

40:152-164	NULL
.	NULL

60	NULL
.	NULL

Umayahara	NULL
,	NULL
Y.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Estrogen	NULL
regulation	NULL
of	NULL
the	NULL
insulin-like	NULL
growth	NULL
factor	NULL
I	NULL
gene	NULL
transcription	NULL
involves	NULL
an	NULL
AP-1	NULL
enhancer	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:16433-16442	NULL
.	NULL

61	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
,	NULL
Gorospe	NULL
,	NULL
M.	NULL
,	NULL
Yang	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Holbrook	NULL
,	NULL
N.J.	NULL
1995	NULL
.	NULL

Role	NULL
of	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
phosphatase	NULL
during	NULL
the	NULL
cellular	NULL
response	NULL
to	NULL
genotoxic	NULL
stress	NULL
.	NULL

Inhibition	NULL
of	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
activity	NULL
and	NULL
AP-1-dependent	NULL
gene	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:8377-8380	NULL
.	NULL

62	NULL
.	NULL

Hunter	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
1992	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
transcription	NULL
by	NULL
phos-phorylation	NULL
.	NULL

Cell	NULL
.	NULL

70:375-387	NULL
.	NULL

63.	NULL
van	NULL
Dam	NULL
,	NULL
H.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
.	NULL

Heterodimer	NULL
formation	NULL
of	NULL
cJun	NULL
and	NULL
ATF-2	NULL
is	NULL
responsible	NULL
for	NULL
induction	NULL
of	NULL
c-jun	NULL
by	NULL
the	NULL
243	NULL
amino	NULL
acid	NULL
adenovirus	NULL
EIA	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:479-487	NULL
.	NULL

64	NULL
.	NULL

Bradbeer	NULL
,	NULL
J.N	NULL
.	NULL

,	NULL
Stroup	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Hoffman	NULL
,	NULL
J.C.	NULL
,	NULL
and	NULL
Gowen	NULL
,	NULL
M.	NULL
1996	NULL
.	NULL

An	NULL
orally	NULL
active	NULL
inhibitor	NULL
of	NULL
cytokine	NULL
synthesis	NULL
prevents	NULL
bone	NULL
loss	NULL
in	NULL
the	NULL
ovariectomized	NULL
rat	NULL
.	NULL

J	NULL
.	NULL

Bone	NULL
Min	NULL
.	NULL

Res	NULL
.	NULL

11	NULL
(	NULL
Suppl	NULL
.	NULL

(	NULL
Abstr	NULL
.	NULL
)	NULL

65	NULL
.	NULL

Gupta	NULL
,	NULL
S.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Selective	NULL
interaction	NULL
of	NULL
JNK	NULL
protein	NULL
kinase	NULL
iso-forms	NULL
with	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:2760-2770	NULL
.	NULL

66	NULL
.	NULL

Whitmarsh	NULL
,	NULL
AJ	NULL
.	NULL

,	NULL
and	NULL
Davis	NULL
,	NULL
RJ	NULL
.	NULL

1996	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-1	NULL
regulation	NULL
by	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

_J	NULL
.	NULL

Mol	NULL
.	NULL

Med	NULL
.	NULL

74:589-607	NULL
.	NULL

67	NULL
.	NULL

Pacifici	NULL
,	NULL
R.	NULL
1996	NULL
.	NULL

Estrogen	NULL
,	NULL
cytokines	NULL
and	NULL
pathogenesis	NULL
of	NULL
postmenopausal	NULL
osteoporosis	NULL
.	NULL

J	NULL
.	NULL

Bone	NULL
Miner	NULL
.	NULL

Res	NULL
.	NULL

11:1043-1051	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Clinical	NULL
Investigation	NULL
|	NULL
August	NULL
1999	NULL
|	NULL
Volume104	NULL
|	NULL
Number4	NULL
513	NULL

